[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 173
1. Miller CE: Unmet therapeutic needs for uterine myomas. J Minim Invasive Gynecol; 2009 Jan-Feb;16(1):11-21
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Unmet therapeutic needs for uterine myomas.
  • Uterine myomas may develop in many women, but only become clinically significant in about one third of the affected population.
  • Although uterine myomas are most often benign, they are associated with debilitating symptoms and commonly result in hysterectomy.
  • Current treatments for uterine myomas include pharmacologic therapies, delivery of focused energy, alteration of uterine vascular supply, or surgical procedures.
  • Factors such as the woman's desire for future pregnancy, the importance of uterine preservation, symptom severity, and tumor characteristics direct the choice of therapeutic approach.
  • The ideal treatment will have the following characteristics: easy to perform, minimally invasive, cost effective, preserves fertility, preserves the uterus, efficacious, acceptable tolerability and durability, and low incidence of myoma recurrence.
  • [MeSH-major] Gynecologic Surgical Procedures / methods. Laparoscopy / methods. Leiomyomatosis / surgery. Uterine Neoplasms / surgery
  • [MeSH-minor] Female. Forecasting. Humans. Uterine Artery Embolization

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19110181.001).
  • [ISSN] 1553-4650
  • [Journal-full-title] Journal of minimally invasive gynecology
  • [ISO-abbreviation] J Minim Invasive Gynecol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 110
  •  go-up   go-down


2. Guo N, Liu H, Peng Z: A mesenteric paraganglioma. J Clin Neurosci; 2009 Dec;16(12):1650-1
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • It is a rare and unusual tumor, especially in non-typical sites such as the inferior mesenteric artery.
  • She was found to have an immobile solid mass on the left side of her pelvis, adjacent to the upper segment of the uterus.
  • CT scans revealed a well-defined solid and cystic ovoid mass adjacent to the sigmoid colon and the uterus.
  • Tumor markers were within the normal range.
  • An intra-operative frozen section biopsy showed a benign cystic tumor.
  • [MeSH-major] Mesentery / pathology. Paraganglioma / pathology. Vascular Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19767210.001).
  • [ISSN] 1532-2653
  • [Journal-full-title] Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
  • [ISO-abbreviation] J Clin Neurosci
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Scotland
  •  go-up   go-down


3. Folpe AL, Mentzel T, Lehr HA, Fisher C, Balzer BL, Weiss SW: Perivascular epithelioid cell neoplasms of soft tissue and gynecologic origin: a clinicopathologic study of 26 cases and review of the literature. Am J Surg Pathol; 2005 Dec;29(12):1558-75
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Perivascular epithelioid cell neoplasms of soft tissue and gynecologic origin: a clinicopathologic study of 26 cases and review of the literature.
  • This family of tumors includes angiomyolipoma (AML), clear cell sugar tumor of the lung (CCST), lymphangioleiomyomatosis (LAM), and very rare tumors in other locations.
  • Because non-AML/non-LAM PEComas are extremely rare and their natural history and prognostic features undefined, we present our experience with 26 PEComas of soft tissue and the gynecologic tract, the largest series to date.
  • Sites of involvement included the omentum or mesentery (6 cases), uterus (4 cases), pelvic soft tissues (3 cases), abdominal wall (2 cases), uterine cervix (2 cases), and vagina, retroperitoneum, thigh, falciform ligament, scalp, broad ligament, forearm, shoulder, and neck (1 case each).
  • The tumors ranged from 1.6 to 29 cm in size (median, 7.8 cm).
  • Tumors were epithelioid (N = 9), spindled (N = 7), or mixed (N = 10).
  • Recurrence and/or metastasis was strongly associated tumor size > median size (8 cm), mitotic activity greater than 1/50 HPF, and necrosis.
  • We conclude that PEComas of soft tissue and gynecologic origin may be classified as "benign," "of uncertain malignant potential," or "malignant."
  • Small PEComas without any worrisome histologic features are most likely benign.
  • [MeSH-major] Biomarkers, Tumor / analysis. Epithelioid Cells / pathology. Genital Neoplasms, Female / pathology. Neoplasms, Connective and Soft Tissue / pathology
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Disease-Free Survival. Female. Follow-Up Studies. Humans. Immunohistochemistry. Immunophenotyping. Male. Middle Aged. Mitosis. Neoplasm Metastasis. Neoplasm Recurrence, Local. Retrospective Studies. Survival Analysis. Time Factors. Treatment Outcome. Tumor Burden

  • COS Scholar Universe. author profiles.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16327428.001).
  • [ISSN] 0147-5185
  • [Journal-full-title] The American journal of surgical pathology
  • [ISO-abbreviation] Am. J. Surg. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Comparative Study; Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  • [Number-of-references] 56
  •  go-up   go-down


Advertisement
4. Sung CO, Ahn G, Song SY, Choi YL, Bae DS: Atypical leiomyomas of the uterus with long-term follow-up after myomectomy with immunohistochemical analysis for p16INK4A, p53, Ki-67, estrogen receptors, and progesterone receptors. Int J Gynecol Pathol; 2009 Nov;28(6):529-34
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Atypical leiomyomas of the uterus with long-term follow-up after myomectomy with immunohistochemical analysis for p16INK4A, p53, Ki-67, estrogen receptors, and progesterone receptors.
  • Atypical leiomyomas are characterized by moderately to severely pleomorphic atypical tumor cells with low mitotic counts and no coagulative tumor cell necrosis.
  • Despite the worrisome histologic features, most tumors have shown benign behavior.
  • [MeSH-major] Biomarkers, Tumor / analysis. Leiomyoma / metabolism. Leiomyoma / surgery. Uterine Neoplasms / metabolism. Uterine Neoplasms / surgery
  • [MeSH-minor] Adult. Cyclin-Dependent Kinase Inhibitor p16 / biosynthesis. Female. Follow-Up Studies. Humans. Immunohistochemistry. Ki-67 Antigen / biosynthesis. Middle Aged. Receptors, Estrogen / biosynthesis. Receptors, Progesterone / biosynthesis. Tumor Suppressor Protein p53 / biosynthesis

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • MedlinePlus Health Information. consumer health - Uterine Fibroids.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19851199.001).
  • [ISSN] 1538-7151
  • [Journal-full-title] International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists
  • [ISO-abbreviation] Int. J. Gynecol. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Cyclin-Dependent Kinase Inhibitor p16; 0 / Ki-67 Antigen; 0 / Receptors, Estrogen; 0 / Receptors, Progesterone; 0 / Tumor Suppressor Protein p53
  •  go-up   go-down


5. Koyama T, Togashi K: Functional MR imaging of the female pelvis. J Magn Reson Imaging; 2007 Jun;25(6):1101-12
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Cine MRI is a useful tool for evaluating uterine contractility, including sustained contraction and peristalsis, in a variety of conditions and gynecologic disorders, and for evaluating pelvic-floor weakness.
  • It also enables the quantitative evaluation of the apparent diffusion coefficient (ADC), which may be useful for distinguishing malignant from benign tissues and monitoring therapeutic outcome.
  • DCE-MRI has the potential to improve tumor detection and local staging, and can also provide quantitative information about perfusion of the tumor, which may be useful for both monitoring therapeutic effects and predicting therapeutic outcome.
  • [MeSH-major] Genital Diseases, Female / diagnosis. Magnetic Resonance Imaging / methods. Pelvis / pathology
  • [MeSH-minor] Contrast Media. Diagnosis, Differential. Female. Humans. Image Processing, Computer-Assisted. Uterine Contraction / physiology. Uterus / pathology

  • MedlinePlus Health Information. consumer health - MRI Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2007 Wiley-Liss, Inc.
  • (PMID = 17520731.001).
  • [ISSN] 1053-1807
  • [Journal-full-title] Journal of magnetic resonance imaging : JMRI
  • [ISO-abbreviation] J Magn Reson Imaging
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Contrast Media
  • [Number-of-references] 101
  •  go-up   go-down


6. Lazović G, Milićević S, Atanacković J, Milosevic V, Bozanović T, Gojnić M: Leiomyoma of the uterus and retroperitoneal angioleiomyoma: case report. Clin Exp Obstet Gynecol; 2007;34(4):257-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Leiomyoma of the uterus and retroperitoneal angioleiomyoma: case report.
  • Retroperitoneal angioleiomyoma is a benign mesenchymal neoplasm that is composed of smooth muscle cells and thick-walled vessels.
  • In a 36-year-old patient a retrouterine and retroperitoneal tumor, 70 x 65 x 50 mm in size, was discovered during a surgical procedure due to uterine myoma.
  • The tumor had a soft consistency and was completely removed.
  • Angioleiomyoma is a rare benign entity; hence a benign course and good prognosis are expected.
  • [MeSH-major] Angiomyoma / complications. Leiomyoma / complications. Retroperitoneal Neoplasms / complications. Uterine Neoplasms / complications

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • MedlinePlus Health Information. consumer health - Uterine Fibroids.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18225694.001).
  • [ISSN] 0390-6663
  • [Journal-full-title] Clinical and experimental obstetrics & gynecology
  • [ISO-abbreviation] Clin Exp Obstet Gynecol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


7. Carranza Lira S: [Relation between hormonal therapy and tibolone with SERMs in postmenopausal women's myomes growth]. Ginecol Obstet Mex; 2008 Oct;76(10):610-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Transliterated title] Relación de la terapia hormonal, la tibolona y los SERMs con el crecimiento de miomas en la mujer posmenopáusica.
  • Myomas (both leiomyomas and fibromas) are the most frequent benign uterine tumors in women, they can be found in 77% of hysterectomy specimens.
  • A study in patients without myomas demonstrated this type tumors production (5%) after receiving transdermical-oral hormonal combination during 24 months, and they were absent in patients with only oral therapy.
  • [MeSH-major] Estrogen Receptor Modulators / adverse effects. Hormone Replacement Therapy / adverse effects. Leiomyoma / pathology. Norpregnenes / adverse effects. Postmenopause. Selective Estrogen Receptor Modulators / adverse effects. Uterine Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Hormone Replacement Therapy.
  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • MedlinePlus Health Information. consumer health - Uterine Fibroids.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19062511.001).
  • [ISSN] 0300-9041
  • [Journal-full-title] Ginecología y obstetricia de México
  • [ISO-abbreviation] Ginecol Obstet Mex
  • [Language] spa
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] Mexico
  • [Chemical-registry-number] 0 / Estrogen Receptor Modulators; 0 / Norpregnenes; 0 / Selective Estrogen Receptor Modulators; FF9X0205V2 / tibolone
  • [Number-of-references] 34
  •  go-up   go-down


8. García Rinaldi R, Pérez Hernández J, Corbalá AR, Aponte HR, Dayán V, Plaza M: Surgical treatment of multiple intracardiac and pulmonary artery tumor implants embolic from uterine intravascular leiomyomatosis. Bol Asoc Med P R; 2007 Jan-Mar;99(1):51-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Surgical treatment of multiple intracardiac and pulmonary artery tumor implants embolic from uterine intravascular leiomyomatosis.
  • Intravenous uterine leiomyomatosis is the invasion of the para-uterine veins by bundles of benign uterine muscle.
  • The tricuspid valve that was rendered insufficient, was repaired by the creation of PTFE neo chordae.
  • Two weeks later a massively enlarged uterus, ovaries, a paracolic and three intraluminal masses in the inferior vena cava were removed.
  • Patients presenting with cardiac tumors from intravenous uterine leiomyomatosis must undergo aggressive surgical management to achieve a cure.
  • [MeSH-major] Heart Neoplasms / secondary. Heart Neoplasms / surgery. Leiomyomatosis / pathology. Leiomyomatosis / surgery. Neoplastic Cells, Circulating. Pulmonary Artery. Uterine Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17616048.001).
  • [ISSN] 0004-4849
  • [Journal-full-title] Boletín de la Asociación Médica de Puerto Rico
  • [ISO-abbreviation] Bol Asoc Med P R
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Puerto Rico
  •  go-up   go-down


9. Auguściak-Duma A, Sieroń AL: [Molecular characteristics of leiomyoma uteri based on selected compounds of the extracellular matrix]. Postepy Hig Med Dosw (Online); 2008 Jan 14;62:148-65
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Leiomyoma is a monoclonal benign tumor.
  • It is often located in the muscle layer of the uterus in women of reproductive age.
  • The modulation of mitotic activity and abnormal extracellular matrix production are key elements of tumor growth.
  • The detectable karyotype anomalies in tumor cells constitute just 40%.

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • MedlinePlus Health Information. consumer health - Uterine Fibroids.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18464678.001).
  • [ISSN] 1732-2693
  • [Journal-full-title] Postepy higieny i medycyny doswiadczalnej (Online)
  • [ISO-abbreviation] Postepy Hig Med Dosw (Online)
  • [Language] POL
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] Poland
  • [Chemical-registry-number] 0 / Bone Morphogenetic Proteins; 0 / Extracellular Matrix Proteins; 0 / Glycoproteins; 0 / PCOLCE protein, human; 0 / Transforming Growth Factor beta1; 0 / Transforming Growth Factor beta3; EC 3.4.24.- / Metalloendopeptidases; EC 3.4.24.19 / BMP1 protein, human; EC 3.4.24.19 / Bone Morphogenetic Protein 1
  • [Number-of-references] 136
  •  go-up   go-down


10. Garteiz-Martínez D, Romero-Lagarza P, Maya-Goldsmit D, Weber-Sánchez A, Bravo-Torreblanca C, Carbo-Romano R, Vega-Rivera F: [Pelvic solitary fibrous nodule, incidental finding and laparoscopic resection. Case report]. Ginecol Obstet Mex; 2010 Sep;78(9):504-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Transliterated title] Nódulo fibroso solitario pélvico, hallazgo incidental y resección laparoscópica. Reporte de un caso.
  • This type of tumors can have malignant components and therefore it is important to differentiate them from other retroperitoneal masses.
  • A peritoneal pelvic tumor with smooth surface, 20,2 g, firm was detected.
  • The mass was independent of colon, uterus, ovaries or salpinx and was very near to the iliac vessels on the right side.
  • The histopathologic report described that the tumor contained sclerosed cells with collagenous bands and sings of hemorrhage and calcification, compatible with a benign pelvic solitary fibrous tumor.
  • The solitary fibrous nodule is a rare, benign disease, but with malignant potential.
  • These tumors must be resected when they are incidentally found during other surgical procedures or if diagnosed preoperatively.
  • The laparoscopic approach has advantages in the identification and resection these tumors.
  • [MeSH-major] Fibroma / complications. Peritoneal Neoplasms / complications. Pregnancy Complications, Neoplastic / diagnosis. Pregnancy, Ectopic / surgery
  • [MeSH-minor] Adult. Female. Humans. Incidental Findings. Laparoscopy. Pregnancy. Uterine Hemorrhage / etiology

  • MedlinePlus Health Information. consumer health - Ectopic Pregnancy.
  • MedlinePlus Health Information. consumer health - Tumors and Pregnancy.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21961368.001).
  • [ISSN] 0300-9041
  • [Journal-full-title] Ginecología y obstetricia de México
  • [ISO-abbreviation] Ginecol Obstet Mex
  • [Language] spa
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Mexico
  •  go-up   go-down


11. Chen XD, Shi HY, Zhang XF: [Clinicopathologic analysis of 102 cases of mixed epithelial and mesenchymal tumors of the uterus]. Zhonghua Fu Chan Ke Za Zhi; 2007 Apr;42(4):219-21
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Clinicopathologic analysis of 102 cases of mixed epithelial and mesenchymal tumors of the uterus].
  • OBJECTIVE: To study the clinical and pathologic features, histological criteria and pathologic factors contributing to diagnosis of mixed epithelial and mesenchymal tumors (mixed müllerian tumors, MMT) of the uterus.
  • METHODS: A retrospective study of 102 cases of MMT of the uterus (74 adenofibromas including 9 recurrent cases, 3 atypical polypoid adenomyomas, 2 carcinofibromas, 10 adenosarcomas and 13 carcinosarcomas) was undertaken.
  • Clinical signs included pelvic mass, uterine polyps, and enlarged uterus.
  • Benign MMT usually presented as exophytic polypoid masses extending into the uterine cavity or protruding through the external os, often broad-based, lobulated and papillary.
  • It was hard to distinguish low-grade malignant MMT from the benign ones by gross appearance.
  • MMT were classified according to whether these elements were benign or malignant.
  • Nine cases of adenofibroma without unique features for the diagnosis of adenosarcoma recurred at postoperative intervals of 3 to 96 months.
  • Recurrent tumors were almost always confined to the original site.
  • CONCLUSIONS: Uterine MMT tumors according to WHO diagnostic criteria are not rare.
  • The differential diagnosis depends on a multifactorial analysis.
  • The recurrent adenofibromas may be a kind of borderline tumors with benign appearances and malignant behavior.
  • [MeSH-major] Mixed Tumor, Mullerian / pathology. Uterine Neoplasms / pathology
  • [MeSH-minor] Adenofibroma / pathology. Adenomyoma / pathology. Adolescent. Adult. Aged. Aged, 80 and over. Diagnosis, Differential. Epithelium / pathology. Female. Humans. Middle Aged. Neoplasm Recurrence, Local. Retrospective Studies

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17631758.001).
  • [ISSN] 0529-567X
  • [Journal-full-title] Zhonghua fu chan ke za zhi
  • [ISO-abbreviation] Zhonghua Fu Chan Ke Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


12. Abu J, Ireland D, Brown L: Adenosarcoma of an endometrial polyp in a 27-year-old nulligravida: a case report. J Reprod Med; 2007 Apr;52(4):326-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Endometrial adenosarcoma is a rare tumor first described by Clement and Scully in 1974.
  • It consists of benign or atypical neoplastic glands within a sarcomatous stroma and represents approximately 8% of all uterine sarcomas.
  • On examination, tissue protruding from the external cervical os is a common finding, with a smaller number of patients having an enlarged uterus or palpable pelvic mass.
  • [MeSH-major] Adenosarcoma / surgery. Endometrial Neoplasms / surgery. Fertility / physiology. Polyps / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17506376.001).
  • [ISSN] 0024-7758
  • [Journal-full-title] The Journal of reproductive medicine
  • [ISO-abbreviation] J Reprod Med
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


13. Canis M, Jardon K, Niro J, Rabischong B, Bourdel N, Botchorishvili R, Pouly JL, Mage G: [Endoscopic management of gynecological malignancies: an update. 2007]. Bull Acad Natl Med; 2007 Oct;191(7):1357-65; discussion 1365-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Transliterated title] Coelioscopie et cancer en gynécologie: le point en 2007.
  • Animal studies suggest that the risk of tumor dissemination in the non traumatized peritoneum may be higher after pneumoperitoneum than after laparotomy, and they also show the importance of the surgeon's experience and technique.
  • By controlling these parameters we may, in future, be able to create a peritoneal environment suitable for oncologic indications and thereby prevent or minimize the risk of peritoneal dissemination and postoperative tumor growth.
  • In endometrial cancer, the laparoscopic approach should be reserved for clinical stage I disease, if the volume of the uterus and local conditions are appropriate for vaginal extraction.
  • Laparoscopy is the gold standard for surgical diagnosis of adnexal masses, but puncture should be avoided whenever possible.
  • In contrast, restaging of early ovarian cancer initially managed as a benign mass is a good indication for the laparoscopic approach.
  • Laparoscopic management of tumors with low malignant potential should include complete staging of the peritoneum.
  • [MeSH-major] Endoscopy / methods. Genital Neoplasms, Female / surgery. Gynecologic Surgical Procedures / methods
  • [MeSH-minor] Animals. Carcinoma / secondary. Carcinoma / surgery. Endometrial Neoplasms / surgery. Female. Humans. Neoplasm Seeding. Ovarian Neoplasms / diagnosis. Ovarian Neoplasms / pathology. Ovarian Neoplasms / surgery. Peritoneal Neoplasms / secondary. Pneumoperitoneum, Artificial / adverse effects. Pneumoperitoneum, Artificial / methods. Swine. Uterine Cervical Neoplasms / surgery

  • MedlinePlus Health Information. consumer health - Endoscopy.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18447057.001).
  • [ISSN] 0001-4079
  • [Journal-full-title] Bulletin de l'Académie nationale de médecine
  • [ISO-abbreviation] Bull. Acad. Natl. Med.
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] Netherlands
  • [Number-of-references] 30
  •  go-up   go-down


14. van den Brink-Knol H, van Esch E: Spontaneous malignant mixed Müllerian tumor in a Wistar rat: a case report including immunohistochemistry. Vet Pathol; 2010 Nov;47(6):1105-10
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Spontaneous malignant mixed Müllerian tumor in a Wistar rat: a case report including immunohistochemistry.
  • This report presents a rare, spontaneous, heterologous, malignant mixed Müllerian tumor observed in a 98-week-old untreated Wistar rat.
  • At necropsy, the right uterine horn was dilated and contained a mass of approximately 10 × 15 mm.
  • Histopathologically the mass consisted of 2 parts with different morphologic characteristics, a polypoid mass protruding into the uterine lumen and a more solid part that replaced the adjacent uterine wall.
  • The solid part exhibited characteristics of a highly infiltrative adenocarcinoma, whereas the composition of the polypoid mass was heterogeneous, consisting of a variety of benign and malignant epithelial and mesenchymal elements.
  • Immunohistochemical analysis further supported the diagnosis of malignant mixed Müllerian tumor.
  • [MeSH-major] Mixed Tumor, Mullerian / veterinary. Rats, Wistar. Uterine Neoplasms / veterinary
  • [MeSH-minor] Animals. Animals, Laboratory / anatomy & histology. Female. Rats. Uterus / pathology

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20587687.001).
  • [ISSN] 1544-2217
  • [Journal-full-title] Veterinary pathology
  • [ISO-abbreviation] Vet. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


15. Dilbaz B, Bayoglu Y, Oral S, Cavusoglu D, Uluoglu O, Dilbaz S: Laparoscopic resection of urinary bladder paraganglioma: a case report. Surg Laparosc Endosc Percutan Tech; 2006 Feb;16(1):58-61
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • She was diagnosed to have an immobile solid mass on the left side neighboring the lower segment of the uterus.
  • Transvaginal ultrasonography revealed a well-limited ovoid mass with solid and cystic areas adjacent to the urinary bladder and the uterus.
  • Tumor markers were within normal range.
  • Frozen section was performed revealing a benign cystic structure but the identification of the origin was left to definitive histopathological examination which showed paraganglioma of the bladder.
  • Immunohistochemically, the tumor cells were strongly positive for chromogranin A and synaptophysin and there was focal positiveness for neuron specific enolase although vimentin and cytokeratin were negative.
  • [MeSH-major] Paraganglioma / surgery. Urinary Bladder Neoplasms / surgery

  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16552385.001).
  • [ISSN] 1530-4515
  • [Journal-full-title] Surgical laparoscopy, endoscopy & percutaneous techniques
  • [ISO-abbreviation] Surg Laparosc Endosc Percutan Tech
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


16. Rubod C, Mubiayi N, Verhulst P, Robert Y, Vinatier D: [Uterine intravenous leiomyomatosis. A case report]. Gynecol Obstet Fertil; 2005 Dec;33(12):991-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Uterine intravenous leiomyomatosis. A case report].
  • Uterine intravenous leiomyomatosis is a rare benign tumor.
  • We report the case of a 41-year-old woman, with no history, who presented an abdominopelvic mass arising from the uterus.
  • Histological examination revealed uterine intravenous leiomyomatosis.
  • The specificity of this tumor is hormonodependency and potential vascular extension.
  • [MeSH-major] Leiomyomatosis / diagnosis. Neoplasms, Hormone-Dependent / diagnosis. Uterine Neoplasms / diagnosis. Vascular Neoplasms / diagnosis
  • [MeSH-minor] Adult. Female. Humans. Hysterectomy. Neoplasm Invasiveness

  • Genetic Alliance. consumer health - Intravenous leiomyomatosis.
  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16324869.001).
  • [ISSN] 1297-9589
  • [Journal-full-title] Gynécologie, obstétrique & fertilité
  • [ISO-abbreviation] Gynecol Obstet Fertil
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] France
  •  go-up   go-down


17. Del Carmen MG: Mesenchymal Tumors of the Female Genital Tract: Treatment. Surg Pathol Clin; 2009 Dec;2(4):835-48
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mesenchymal Tumors of the Female Genital Tract: Treatment.
  • Mesenchymal tumors of the female genital tract include various benign and malignant neoplasms.
  • Mesenchymal tumors may arise from the stroma or associated elements of the organ of origin, such as connective tissue, vascular or neural structures, or others.
  • Malignant mesenchymal tumors of the female genital tract represent a rare group of gynecologic cancers.
  • They are generally aggressive tumors, with a propensity for local and distant recurrence.
  • The mainstay of treatment usually involves surgical excision of the primary tumor.
  • Malignant mesenchymal tumors of the female genital tract are generally refractory to systemic chemotherapy and radiation therapy.
  • This review highlights the treatment options for the most common types of mesenchymal tumors of the female genital tract.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2009 Elsevier Inc. All rights reserved.
  • (PMID = 26838782.001).
  • [ISSN] 1875-9181
  • [Journal-full-title] Surgical pathology clinics
  • [ISO-abbreviation] Surg Pathol Clin
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Keywords] NOTNLM ; Female genital tract / Mesenchymal tumors / Ovary / Treatment / Uterus / Vagina / Vulva
  •  go-up   go-down


18. Canis M, Farina M, Jardon K, Rabischong B, Rivoire C, Nohuz E, Botchorishvili R, Pouly JL, Mage G: [Laparoscopy and gynecologic cancer in 2005]. J Gynecol Obstet Biol Reprod (Paris); 2006 Apr;35(2):117-35
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Transliterated title] Coelioscopie et cancer en gynécologie: le point en 2005.
  • Animal studies suggested that the risk of tumor dissemination in non traumatized peritoneum is higher after a pneumoperitoneum than after a laparotomy.
  • Changing these parameters we may, in the future, be able to create a peritoneal environment adapted to oncologic patients in order to prevent or to decrease the risks of peritoneal dissemination and/or of postoperative tumor growth.
  • In patients with endometrial cancer, the laparoscopic approach should be reserved to clinical stage I disease, if the vaginal extraction is anticipated to be easy accounting for the volume of the uterus and the local conditions.
  • Laparoscopy is the gold standard for the surgical diagnosis of adnexal masses.
  • In contrast restaging of an early ovarian cancer initially managed as a benign mass, is a good indication of the laparoscopic approach.
  • The laparoscopic management of low malignant potential tumors should include a complete staging of the peritoneum.
  • [MeSH-major] Genital Neoplasms, Female / surgery. Laparoscopy
  • [MeSH-minor] Animals. Endometrial Neoplasms / pathology. Endometrial Neoplasms / surgery. Female. Humans. Neoplasm Invasiveness. Neoplasm Metastasis. Neoplasm Staging. Ovarian Neoplasms / pathology. Ovarian Neoplasms / surgery. Peritoneal Neoplasms / epidemiology. Peritoneal Neoplasms / etiology. Pneumoperitoneum, Artificial / adverse effects. Risk Factors. Uterine Cervical Neoplasms / pathology. Uterine Cervical Neoplasms / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16575358.001).
  • [ISSN] 0368-2315
  • [Journal-full-title] Journal de gynécologie, obstétrique et biologie de la reproduction
  • [ISO-abbreviation] J Gynecol Obstet Biol Reprod (Paris)
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] France
  • [Number-of-references] 190
  •  go-up   go-down


19. Karpathiou G, Sivridis E, Giatromanolaki A: Myxoid leiomyosarcoma of the uterus: a diagnostic challenge. Eur J Gynaecol Oncol; 2010;31(4):446-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Myxoid leiomyosarcoma of the uterus: a diagnostic challenge.
  • Myxoid leiomyosarcoma is an extremely rare variant of leiomyosarcoma, masquerading almost to perfection as a benign lesion.
  • For, indeed, the tumor lacks the defining features of high mitotic activity, cellular atypia or necrosis, and the microscopic picture is dominated by abundant myxoid stroma containing sparse spindle cells.
  • We report here such a case occurring in the uterus and discuss the differential diagnosis.
  • [MeSH-major] Leiomyosarcoma / diagnosis. Uterine Neoplasms / diagnosis
  • [MeSH-minor] Adult. Diagnosis, Differential. Female. Humans

  • Genetic Alliance. consumer health - Leiomyosarcoma.
  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20882892.001).
  • [ISSN] 0392-2936
  • [Journal-full-title] European journal of gynaecological oncology
  • [ISO-abbreviation] Eur. J. Gynaecol. Oncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


20. Guajado Martínez J, Maldonado Alvarado Jde D, Cárdenas Ochoa J, Saídivar Ornelas E, Villeda C: [Giant ovarian cyst extraction by means of minilaparotomy: hourglass technique]. Ginecol Obstet Mex; 2008 Dec;76(12):739-43
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Transliterated title] Extracción de quiste gigante de ovario por minilaparotomía: técnica de reloj de arena.
  • Cervix of uterus was hardly seen due to its small size, without evident damage; nor uterus nor appendages can be delimited during vaginal touch.
  • When tumor tension decreases it was placed a Mayo table with sterile fields next to surgical table, and the abdomen was pulled laterally until tumor protrusion trough surgical incision, liquid weight puts tumor out of the abdomen.
  • Cyst total weight was 55 kg, and hystopathological report was benign serous giant ovarian cyst.

  • MedlinePlus Health Information. consumer health - Ovarian Cysts.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [ErratumIn] Ginecol Obstet Mex. 2009 Jan;77(1):12
  • (PMID = 19149403.001).
  • [ISSN] 0300-9041
  • [Journal-full-title] Ginecología y obstetricia de México
  • [ISO-abbreviation] Ginecol Obstet Mex
  • [Language] spa
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Mexico
  •  go-up   go-down


21. Horn LC, Dallacker M, Bilek K: [Carcinosarcomas (malignant mixed Mullerian tumors) of the uterus. Morphology, pathogenetic aspects and prognostic factors]. Pathologe; 2009 Jul;30(4):292-301
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Carcinosarcomas (malignant mixed Mullerian tumors) of the uterus. Morphology, pathogenetic aspects and prognostic factors].
  • [Transliterated title] Karzinosarkome (maligne Müller-Mischtumoren) des Uterus. Morphologie, molekulare Pathogenese und morphologische Prognosefaktoren.
  • Malignant mixed Mullerian tumors (MMMT; carcinosarcomas) are rare epithelial-mesenchymal tumors.
  • Clinical, morphologic and molecular data suggest that MMMTs are really metaplastic carcinomas in which the mesenchymal part retains epithelial features.
  • The strongest prognostic factor is tumor stage followed by lymph node metastases, deep myometrial infiltration, involvement of the cervix and tumor size.
  • The main differential diagnoses include uterine sarcomas, adenosarcoma and benign metaplastic change within the endometrium.
  • [MeSH-major] Carcinosarcoma / pathology. Uterine Neoplasms / pathology
  • [MeSH-minor] Carcinoma, Endometrioid / pathology. Cervix Uteri / pathology. Female. Humans. Immunohistochemistry / methods. Lymphatic Metastasis. Myometrium / pathology. Neoplasm Staging. Prognosis. Survival Rate. Uterine Cervical Neoplasms / pathology. Uterine Cervical Neoplasms / radiotherapy

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Lancet Oncol. 2005 Dec;6(12):961-71 [16321764.001]
  • [Cites] Gynecol Oncol. 1997 Dec;67(3):316-21 [9441781.001]
  • [Cites] Int J Gynecol Pathol. 1990;9(1):1-19 [2152890.001]
  • [Cites] Gynecol Oncol. 2005 Aug;98(2):274-80 [15972232.001]
  • [Cites] Cancer. 2000 Jun 15;88(12):2782-6 [10870061.001]
  • [Cites] Gynecol Oncol. 2006 Nov;103(2):684-7 [16797683.001]
  • [Cites] Anticancer Res. 2001 Jul-Aug;21(4B):3069-74 [11712812.001]
  • [Cites] J Clin Pathol. 2002 May;55(5):321-5 [11986333.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2004 Mar 1;58(3):786-96 [14967435.001]
  • [Cites] Int J Gynecol Pathol. 2003 Jan;22(1):75-82 [12496702.001]
  • (PMID = 19495763.001).
  • [ISSN] 1432-1963
  • [Journal-full-title] Der Pathologe
  • [ISO-abbreviation] Pathologe
  • [Language] ger
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


22. Djurdjevic S, Stojanovic S, Kopitovic V, Hadnadjev D, Basta-Nikolic M: Diagnostic value of endosonography scoring systems in the detection of ovarian and endometrial carcinoma. J BUON; 2009 Jan-Mar;14(1):97-102
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • PURPOSE: To evaluate the diagnostic significance of sonographic scoring systems in the diagnosis of ovarian and endometrial carcinoma.
  • PATIENTS AND METHODS: 357 women with different malignant and benign diseases of the ovary and uterus were divided into 4 groups according to histopathological findings: group A: ovarian carcinoma (n=71); group B: benign ovarian tumors (n=106); group C: endometrial carcinoma (n=60); and group D: benign endometrial diseases in menopause (hyperplasia, polyps, submucosal myoma; n=120).
  • Particular morphological characteristics of ovarian carcinoma (tumor size, echo-characterization: solid-cystic, presence of septum, characteristics of tumor capsule and presence of ascites) were evaluated with points 0-2 (total score: 0-10).
  • For endometrial carcinoma we used a clinico-sonographic scoring system, which included evaluation of the endometrial thickness, isthmus-fundus diameter of uterus, number of years in menopause and the presence of risk factors, using scores 0-2 (total score: 0-8).
  • [MeSH-major] Carcinoma / ultrasonography. Endometrial Neoplasms / ultrasonography. Endosonography. Ovarian Neoplasms / ultrasonography

  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19373954.001).
  • [ISSN] 1107-0625
  • [Journal-full-title] Journal of B.U.ON. : official journal of the Balkan Union of Oncology
  • [ISO-abbreviation] J BUON
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article
  • [Publication-country] Greece
  •  go-up   go-down


23. Fatnassi R, Amri F: [Adenosarcoma of the uterus: a case report]. J Gynecol Obstet Biol Reprod (Paris); 2005 May;34(3 Pt 1):270-2
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Adenosarcoma of the uterus: a case report].
  • Adenosarcoma of the uterus has two components: a benign epithelial proliferation and a stromal sarcoma.
  • The purpose of this work was to report the clinical aspects and therapeutic modalities of an exceptional case of uterine adenosarcoma in a 15-year-old girl revealed by pelvic pain.
  • Histology of the mass confirmed the diagnosis of adenosarcoma of the uterus.
  • This rare tumor (8% of uterine sarcomas) generally requires hysterectomy.
  • [MeSH-major] Adenosarcoma / diagnosis. Uterine Neoplasms / diagnosis

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16012388.001).
  • [ISSN] 0368-2315
  • [Journal-full-title] Journal de gynécologie, obstétrique et biologie de la reproduction
  • [ISO-abbreviation] J Gynecol Obstet Biol Reprod (Paris)
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] France
  • [Chemical-registry-number] 0 / Antineoplastic Agents
  •  go-up   go-down


24. Zorio E, Gilabert-Estellés J, España F, Ramón LA, Cosín R, Estellés A: Fibrinolysis: the key to new pathogenetic mechanisms. Curr Med Chem; 2008;15(9):923-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The fibrinolytic system includes a broad spectrum of proteolytic enzymes with physiological and pathophysiological functions in several processes, such as haemostatic balance, tissue remodeling, tumor invasion, angiogenesis and reproduction.
  • Indeed, studies of several types of cancers, including breast cancer, have shown that increased uPA and PAI-1 levels are associated with aggressive tumor behavior and poor prognosis.
  • Endometriosis is defined by the presence of endometrial glands and stroma outside the uterus with marked ability to attach and invade the peritoneum.
  • It is one of the most frequent benign gynecological diseases that affect women with pelvic pain or infertility during their reproductive age.
  • [MeSH-major] Coronary Artery Disease / metabolism. Endometriosis / metabolism. Fibrinolysis. Neoplasms / metabolism. Plasminogen Activators / metabolism. Plasminogen Inactivators / metabolism

  • MedlinePlus Health Information. consumer health - Coronary Artery Disease.
  • MedlinePlus Health Information. consumer health - Endometriosis.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18473800.001).
  • [ISSN] 0929-8673
  • [Journal-full-title] Current medicinal chemistry
  • [ISO-abbreviation] Curr. Med. Chem.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Plasminogen Inactivators; 9001-31-4 / Fibrin; 9001-91-6 / Plasminogen; EC 3.4.21.- / Plasminogen Activators; EC 3.4.21.68 / Tissue Plasminogen Activator; EC 3.4.21.7 / Fibrinolysin; EC 3.4.21.73 / Urokinase-Type Plasminogen Activator; EC 3.4.24.- / Matrix Metalloproteinases
  • [Number-of-references] 163
  •  go-up   go-down


25. Leaha C, Opris I, Macé P, Resch B, Sabourin JC: [Cystic adenomatoid tumor of the uterus]. Ann Pathol; 2009 Apr;29(2):134-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Cystic adenomatoid tumor of the uterus].
  • [Transliterated title] Tumeur adénomatoïde kystique utérine.
  • Adenomatoid tumors are benign neoplasms of mesothelial origin, which involve the feminine and masculine genital tracts.
  • Our study presents an adenomatoid tumour, of cystic shape, which enables discussion of the histogenesis of this tumour and enlightenment of differential diagnoses which can at times result in an incorrect malignant diagnosis.
  • [MeSH-major] Adenomatoid Tumor / pathology. Uterine Neoplasms / pathology
  • [MeSH-minor] Adult. Calbindin 2. Carcinoma, Signet Ring Cell / pathology. Diagnosis, Differential. Epithelium / pathology. Female. Humans. Male. Myometrium / pathology. S100 Calcium Binding Protein G / analysis

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19364588.001).
  • [ISSN] 0242-6498
  • [Journal-full-title] Annales de pathologie
  • [ISO-abbreviation] Ann Pathol
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] France
  • [Chemical-registry-number] 0 / Calbindin 2; 0 / S100 Calcium Binding Protein G
  •  go-up   go-down


26. Manjunatha HK, Ramaswamy AS, Kumar BS, Kumar SP, Krishna L: Lipoleiomyoma of uterus in a postmenopausal woman. J Midlife Health; 2010 Jul;1(2):86-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Lipoleiomyoma of uterus in a postmenopausal woman.
  • Lipoleiomyomas are uncommon benign neoplasms of uterus and are considered to be a variant of uterine myomas.
  • These tumors generally occur in asymptomatic obese perimenopausal or menopausal women.
  • We report this case of uterine lipoleiomyoma because of its rarity.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Korean Med Sci. 2001 Apr;16(2):250-2 [11306758.001]
  • [Cites] Pathology. 1991 Oct;23(4):360-2 [1784529.001]
  • [Cites] Int J Gynaecol Obstet. 1999 Oct;67(1):47-9 [10576241.001]
  • [Cites] Acta Pathol Jpn. 1991 Feb;41(2):164-9 [2042491.001]
  • [Cites] Pathol Res Pract. 1994 Apr;190(4):378-83 [8078806.001]
  • [Cites] Pathologica. 1996 Apr;88(2):132-4 [8927448.001]
  • (PMID = 21716761.001).
  • [ISSN] 0976-7819
  • [Journal-full-title] Journal of mid-life health
  • [ISO-abbreviation] J Midlife Health
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  • [Other-IDs] NLM/ PMC3122497
  • [Keywords] NOTNLM ; Lipoleiomyoma / menopause / smooth muscle / uterus
  •  go-up   go-down


27. Tiutiuca RC, Eva I, Moscalu M, Constantinoiu S: [Study on the evaluation of complementary imaging methods in rectal neoplasia]. Chirurgia (Bucur); 2009 Jul-Aug;104(4):399-407
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Study on the evaluation of complementary imaging methods in rectal neoplasia].
  • The actual strategies of rectal neoplasia's treatment needs an evaluation closer to the reality of the tumor stadium.
  • Imagistic paraclinical exams must bring data about tumor relation with the rectal wall and the mesorectal fascia, the lymph nodes and other important structures invasion.
  • In this purpose it was used a pelvic magnetic resonance imaging (IRM) and computed tomography (CT) comparatively with surgical findings and pathological results on 15 patients with benign and malignant rectal neoplasia, 6 men and 9 females.
  • We apreciate that computed tomography is the choice for imagistic approach of urinary system, mesorectal nodes and uterus and that IRM is best in imagistic evaluation of anterior subperitoneal structures and mesorectal fascia.
  • [MeSH-major] Magnetic Resonance Imaging. Rectal Neoplasms / pathology. Rectal Neoplasms / radiography. Tomography, X-Ray Computed
  • [MeSH-minor] Female. Humans. Male. Neoplasm Invasiveness. Neoplasm Staging. Predictive Value of Tests. Sensitivity and Specificity. Treatment Outcome

  • MedlinePlus Health Information. consumer health - CT Scans.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19886046.001).
  • [ISSN] 1221-9118
  • [Journal-full-title] Chirurgia (Bucharest, Romania : 1990)
  • [ISO-abbreviation] Chirurgia (Bucur)
  • [Language] rum
  • [Publication-type] Comparative Study; English Abstract; Journal Article
  • [Publication-country] Romania
  •  go-up   go-down


28. Jakab C, Rusvai M, Biró N, Szabó Z, Gálfi P, Kulka J: Claudin-5-positive angioleiomyoma in the uterus of a degu (Octodon degus ). Acta Vet Hung; 2010 Sep;58(3):331-40
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Claudin-5-positive angioleiomyoma in the uterus of a degu (Octodon degus ).
  • During ovariohysterectomy a circumscribed tumoural lesion was found in the right uterine horn.
  • The histopathological diagnosis of this soft tissue mass was primary benign cavernous angioleiomyoma of the uterus.
  • During immunohistochemical analysis the neoplastic endothelial cells of this mixed mesenchymal tumour showed strong membrane positivity for the endothelial marker claudin-5 but were negative for CD31 (another endothelial marker).
  • [MeSH-major] Angiomyoma / veterinary. Biomarkers, Tumor / metabolism. Membrane Proteins / metabolism. Octodon. Rodent Diseases / pathology. Uterine Neoplasms / veterinary

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20713324.001).
  • [ISSN] 0236-6290
  • [Journal-full-title] Acta veterinaria Hungarica
  • [ISO-abbreviation] Acta Vet. Hung.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Hungary
  • [Chemical-registry-number] 0 / Antigens, CD31; 0 / Biomarkers, Tumor; 0 / Membrane Proteins
  •  go-up   go-down


29. Manjunath GV, Nandini NM, Sunila: Fine needle aspiration cytology of adenomatoid tumour--a case report with review of literature. Indian J Pathol Microbiol; 2005 Oct;48(4):503-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Fine needle aspiration cytology of adenomatoid tumour--a case report with review of literature.
  • Adenomatoid tumours are neoplasms of male and female genital tract with the epididymis being the most common site.
  • They also occur in uterus, fallopian tube, and ovary.
  • These benign tumours are asymptomatic or cause mild symptoms and a palpable mass.
  • Fine needle aspiration of these tumours is very useful to differentiate malignant from benign lesions and helps to avoid unnecessary aggressive surgical procedures.
  • FNAC of these benign epididymal tumours is diagnostic, rapid, reliable, conclusive and cost effective.
  • We are reporting a case of adenomatoid tumour of epididymis in a 41 year old male patient, diagnosed by FNAC and confirmed by histopathology.
  • [MeSH-major] Adenomatoid Tumor / pathology. Epididymis. Genital Neoplasms, Male / pathology
  • [MeSH-minor] Adult. Biopsy, Fine-Needle. Diagnosis, Differential. Female. Humans. Male

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16366111.001).
  • [ISSN] 0377-4929
  • [Journal-full-title] Indian journal of pathology & microbiology
  • [ISO-abbreviation] Indian J Pathol Microbiol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] India
  • [Number-of-references] 7
  •  go-up   go-down


30. Adachi Y, Horie Y, Kitamura Y, Nakamura H, Taniguchi Y, Miwa K, Fujioka S, Nishimura M, Hayashi K: CD1a expression in PEComas. Pathol Int; 2008 Mar;58(3):169-73
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • According to the World Health Organization classification, neoplasms with perivascular epithelioid cell differentiation (PEComas) are mesenchymal tumors composed of histologically and immunohistochemically distinctive PEC.
  • Recently the authors reported that benign clear cell sugar tumor of the lung, one of the PEComas, expressed CD1a.
  • Nineteen PEComas were obtained, which included angiomyolipoma of the kidney or liver, lymphangiomyomatosis of the uterus or lung and clear cell sugar tumor of the lung.
  • Eighteen tumors had alpha-SMA and HMB-45 expression and 16 had melan A expression.
  • In contrast, all 19 tumors had CD1a expression.
  • [MeSH-major] Antigens, CD1 / metabolism. Biomarkers, Tumor / metabolism. Epithelioid Cells / metabolism. Neoplasms, Connective and Soft Tissue / metabolism

  • antibodies-online. View related products from antibodies-online.com (subscription/membership/fee required).
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18251780.001).
  • [ISSN] 1440-1827
  • [Journal-full-title] Pathology international
  • [ISO-abbreviation] Pathol. Int.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Australia
  • [Chemical-registry-number] 0 / Antigens, CD1; 0 / Biomarkers, Tumor; 0 / CD1a antigen
  •  go-up   go-down


36. Liu P, Chen CL, Zeng BL, Ma B, Zhang H, Qiu YX, Chen LT: [Study of the injury to the urinary system caused by radiological vascular interventional therapy of obstetrical and gynecological benign diseases]. Zhonghua Fu Chan Ke Za Zhi; 2006 Jan;41(1):25-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Study of the injury to the urinary system caused by radiological vascular interventional therapy of obstetrical and gynecological benign diseases].
  • OBJECTIVE: To explore the injuries to the urinary system caused by uterine artery embolization (UAE) for treatment of obstetrical and gynecological benign diseases, including the classification, aetiology, therapy of the injuries and precaution methods.
  • METHODS: The injuries of the urinary system were reviewed in 960 cases of obstetrical and gynecological benign diseases treated with UAE by our interventional centre.
  • The operation procedures of all five cases were bilateral uterine artery embolization, and none used microcatheter. (2) The ureter branch arising from the middle or lower part of the uterine artery supplied the middle or lower part of ureter and the length of this part of ureter is about 4 cm, the bladder branch arising from the middle or lower part of uterine artery supplied the bladder and communicated with the bladder vascular net.
  • Correlative injuries could be caused by the retroflow of embolisms into the above arteries. (3) Placement of the catheter into the upper branch of the uterine artery or the tumor vascular net, using microcatheter if necessary and notation of the retroflow in the embolization process could avoid the embolization of bladder and ureter arteries. (4) Totally 506 cases used microcatheter, the ratio was 52.7%.
  • CONCLUSIONS: Injuries to the urinary system could occur in UAE for treatment of obstetrical and gynecological benign diseases, which can be prevented by carefully differentiating the vascular communicating branch and the conditions of branches, and embolization of the upper branch of uterine artery can avoid the injury.
  • [MeSH-major] Embolization, Therapeutic / adverse effects. Genital Diseases, Female / therapy. Urinary Tract / injuries. Urologic Diseases / etiology. Uterus / blood supply

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16635323.001).
  • [ISSN] 0529-567X
  • [Journal-full-title] Zhonghua fu chan ke za zhi
  • [ISO-abbreviation] Zhonghua Fu Chan Ke Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


37. Zhou M, McFarland-Mancini MM, Funk HM, Husseinzadeh N, Mounajjed T, Drew AF: Toll-like receptor expression in normal ovary and ovarian tumors. Cancer Immunol Immunother; 2009 Sep;58(9):1375-85
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Toll-like receptor expression in normal ovary and ovarian tumors.
  • Tumor cell expression of TLRs can promote inflammation and cell survival in the tumor microenvironment.
  • Here we sought to characterize the expression of TLRs in normal human ovaries, benign and malignant ovarian tumors from patients, and in established ovarian tumor cell lines.
  • In contrast to previous studies of uterus and endocervix, we found no cyclic variation in TLR expression occurred in murine ovaries.
  • TLR2, TLR3, TLR4, and TLR5 are expressed in benign conditions, epithelial tumors, and in ovarian cancer cell lines.
  • Variable expression of TLR6 and TLR8 was seen in benign and malignant epithelium of some patients, while expression of TLR1, TLR7, and TLR9 was weak.
  • Vascular endothelial cells, macrophages, and occasional fibroblasts in tumors were positive.
  • These studies demonstrate expression of multiple TLRs in the epithelium of normal ovaries and in ovarian tumor cells, and may indicate a mechanism by which epithelial tumors manipulate inflammatory pathways to facilitate tumor progression.
  • [MeSH-major] Adenocarcinoma, Clear Cell / metabolism. Cystadenocarcinoma, Serous / metabolism. Ovarian Neoplasms / metabolism. Ovary / metabolism. Toll-Like Receptors / metabolism
  • [MeSH-minor] Adult. Aged. Animals. Epithelial Cells / metabolism. Estrous Cycle / metabolism. Female. Humans. Immunoenzyme Techniques. Mice. Mice, Inbred C57BL. Middle Aged. Prognosis. Tissue Array Analysis. Tumor Cells, Cultured

  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19184006.001).
  • [ISSN] 1432-0851
  • [Journal-full-title] Cancer immunology, immunotherapy : CII
  • [ISO-abbreviation] Cancer Immunol. Immunother.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Toll-Like Receptors
  •  go-up   go-down


38. Wei T, Geiser AG, Qian HR, Su C, Helvering LM, Kulkarini NH, Shou J, N'Cho M, Bryant HU, Onyia JE: DNA microarray data integration by ortholog gene analysis reveals potential molecular mechanisms of estrogen-dependent growth of human uterine fibroids. BMC Womens Health; 2007;7:5
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] DNA microarray data integration by ortholog gene analysis reveals potential molecular mechanisms of estrogen-dependent growth of human uterine fibroids.
  • BACKGROUND: Uterine fibroids or leiomyoma are a common benign smooth muscle tumor.
  • The tumor growth is well known to be estrogen-dependent.
  • METHODS: Differentially expressed genes in human uterine fibroids were either retrieved from published papers or from our own statistical analysis of downloaded array data.
  • RESULTS: By integrated analysis of three recently published DNA microarray studies with human tissue, thirty-eight genes were found to be differentially expressed in the same direction in fibroid compared to adjacent uterine myometrium by at least two research groups.
  • Among these genes, twelve with rat orthologs were identified as estrogen-regulated from our array study investigating uterine expression in ovariectomized rats treated with estrogen.
  • Functional and pathway analyses of the twelve genes suggested multiple molecular mechanisms for estrogen-dependent cell survival and tumor growth.
  • RA has been shown to play a significant role in the development of uterine fibroids in an animal model.
  • CONCLUSION: Integrated analysis of multiple array datasets revealed twelve human and rat ortholog genes that were differentially expressed in human uterine fibroids and transcriptionally responsive to estrogen in the rat uterus.
  • Functional and pathway analysis of these genes suggest multiple potential molecular mechanisms for the poorly understood estrogen-dependent growth of uterine fibroids.
  • Fully understanding the exact molecular interactions among these gene products requires further study to validate their roles in uterine fibroids.
  • [MeSH-major] Estrogens / physiology. Gene Expression. Leiomyoma / genetics. Uterine Neoplasms / genetics
  • [MeSH-minor] Animals. Databases, Genetic. Female. Humans. Myometrium / metabolism. Oligonucleotide Array Sequence Analysis. Rats. Signal Transduction. Tumor Cells, Cultured. Uterus / metabolism

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • MedlinePlus Health Information. consumer health - Uterine Fibroids.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cancer Res. 1999 Nov 15;59(22):5737-44 [10582693.001]
  • [Cites] Biol Reprod. 2005 Apr;72(4):830-41 [15576828.001]
  • [Cites] Eur J Biochem. 2000 Jul;267(14):4315-24 [10880953.001]
  • [Cites] Mol Biol Cell. 2000 Jul;11(7):2283-95 [10888668.001]
  • [Cites] Biochim Biophys Acta. 2000 Oct 18;1482(1-2):259-71 [11058767.001]
  • [Cites] Br J Cancer. 2000 Dec;83(11):1503-9 [11076660.001]
  • [Cites] J Biol Chem. 2000 Dec 15;275(50):39747-53 [10995752.001]
  • [Cites] Neuroreport. 2000 Nov 27;11(17):3719-23 [11117479.001]
  • [Cites] Hum Reprod Update. 2001 Jan-Feb;7(1):8-14 [11212080.001]
  • [Cites] Lancet. 2001 Jan 27;357(9252):293-8 [11214143.001]
  • [Cites] Mediators Inflamm. 2001 Oct;10(5):245-51 [11759108.001]
  • [Cites] Nucleic Acids Res. 2002 Jan 1;30(1):207-10 [11752295.001]
  • [Cites] Genome Res. 2002 Mar;12(3):493-502 [11875039.001]
  • [Cites] Genome Res. 2002 Apr;12(4):656-64 [11932250.001]
  • [Cites] J Clin Endocrinol Metab. 2002 Apr;87(4):1729-36 [11932307.001]
  • [Cites] Gut. 2002 May;50(5):658-64 [11950812.001]
  • [Cites] Aliment Pharmacol Ther. 2002 Apr;16 Suppl 2:67-73 [11966526.001]
  • [Cites] Fertil Steril. 2002 Jul;78(1):114-21 [12095500.001]
  • [Cites] Biol Reprod. 2002 Nov;67(5):1555-64 [12390888.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Jan 7;100(1):318-23 [12518068.001]
  • [Cites] Nucleic Acids Res. 2003 Jan 1;31(1):28-33 [12519941.001]
  • [Cites] Genome Biol. 2003;4(1):R4 [12537549.001]
  • [Cites] Cancer Res. 2003 Mar 15;63(6):1221-7 [12649180.001]
  • [Cites] Mol Endocrinol. 2003 Apr;17(4):562-74 [12554762.001]
  • [Cites] Breast Cancer Res Treat. 2003 May;79(2):149-59 [12825850.001]
  • [Cites] Environ Health Perspect. 2003 Jun;111(8):1037-54 [12826476.001]
  • [Cites] Mol Hum Reprod. 2003 Aug;9(8):481-90 [12837925.001]
  • [Cites] Fertil Steril. 2003 Aug;80(2):266-76 [12909484.001]
  • [Cites] Mol Endocrinol. 2003 Sep;17(9):1844-55 [12829806.001]
  • [Cites] J Biol Chem. 2003 Sep 12;278(37):35819-25 [12842898.001]
  • [Cites] Mol Cell Biol. 2003 Dec;23(23):8651-67 [14612408.001]
  • [Cites] J Steroid Biochem Mol Biol. 2003 Sep;86(3-5):433-42 [14623541.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Dec 9;100(25):15206-11 [14638944.001]
  • [Cites] C R Biol. 2003 Oct-Nov;326(10-11):1075-8 [14744115.001]
  • [Cites] Bioinformatics. 2004 Mar 1;20(4):578-80 [14990455.001]
  • [Cites] Pol J Pharmacol. 2004 Jan-Feb;56(1):5-27 [15047974.001]
  • [Cites] World J Gastroenterol. 2004 Apr 1;10(7):1047-51 [15052691.001]
  • [Cites] Inflamm Res. 2004 Apr;53(4):125-32 [15060718.001]
  • [Cites] Genome Res. 2004 May;14(5):942-50 [15123590.001]
  • [Cites] Gut. 2004 Aug;53(8):1151-8 [15247185.001]
  • [Cites] Endocrinology. 2004 Oct;145(10):4756-62 [15205379.001]
  • [Cites] Fertil Steril. 2004 Sep;82(3):639-49 [15374708.001]
  • [Cites] Mol Cell Biol. 2004 Nov;24(22):9705-25 [15509776.001]
  • [Cites] J Steroid Biochem. 1984 May;20(5):1195-200 [6328123.001]
  • [Cites] Nature. 1986 Mar 13-19;320(6058):134-9 [3754034.001]
  • [Cites] Cell. 1987 Dec 24;51(6):941-51 [3690665.001]
  • [Cites] Fertil Steril. 1989 Feb;51(2):251-6 [2492232.001]
  • [Cites] Acta Endocrinol (Copenh). 1989 Apr;120(4):466-72 [2718698.001]
  • [Cites] Am J Obstet Gynecol. 1990 Aug;163(2):545-50 [2386142.001]
  • [Cites] Receptor. 1993 Spring;3(1):17-30 [8348080.001]
  • [Cites] Eur J Biochem. 1993 Oct 1;217(1):313-8 [8223569.001]
  • [Cites] Hum Reprod. 1993 Nov;8(11):1796-806 [7507128.001]
  • [Cites] Trends Pharmacol Sci. 1994 Mar;15(3):71-6 [8184489.001]
  • [Cites] J Biol Chem. 1995 Mar 10;270(10):5427-33 [7890657.001]
  • [Cites] J Clin Endocrinol Metab. 1996 May;81(5):1967-74 [8626866.001]
  • [Cites] Genome Res. 1996 Jul;6(7):639-45 [8796352.001]
  • [Cites] J Mol Med (Berl). 1996 Jul;74(7):347-52 [8841947.001]
  • [Cites] Gene. 1996 Sep 26;174(1):151-8 [8863742.001]
  • [Cites] Cancer Res. 1999 May 15;59(10):2484-92 [10344762.001]
  • [Cites] Biol Reprod. 2005 Feb;72(2):416-22 [15469997.001]
  • [Cites] Genes Chromosomes Cancer. 2000 Jul;28(3):235-45 [10862029.001]
  • (PMID = 17407572.001).
  • [ISSN] 1472-6874
  • [Journal-full-title] BMC women's health
  • [ISO-abbreviation] BMC Womens Health
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Estrogens
  • [Other-IDs] NLM/ PMC1852551
  •  go-up   go-down


39. Mohr U, Ernst H, Roller M, Pott F: Pulmonary tumor types induced in Wistar rats of the so-called "19-dust study". Exp Toxicol Pathol; 2006 Aug;58(1):13-20
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pulmonary tumor types induced in Wistar rats of the so-called "19-dust study".
  • The incidences of primary lung tumor types histologically diagnosed in 28 groups of Wistar rats of the so-called "19-dust study" are described, the total study having been already presented by Pott and Roller (Carcinogenicity study with nineteen granular dusts in rats.
  • Each exposed group was repeatedly instilled intratracheally with a suspension of one type and dose of 13 non-mining dusts differing in at least one of the following properties: chemical composition, density, specific surface area, and mean particle size.
  • In 579 (58%) lungs of 1002 rats which survived more than 26 weeks after the first instillation of GBP, at least one primary lung tumor type was observed, and in 306 (31%) at least two types.
  • Three benign tumor types were diagnosed in the 579 tumor-bearing rats: bronchiolo-alveolar adenoma in 46%, cystic keratinizing epithelioma in 53%, and non-keratinizing epithelioma in 2.6% of the rats.
  • Two of three malignant tumor types (bronchiolo-alveolar carcinoma and squamous cell carcinoma) occurred in 46% and 31% of the tumor-bearing rats, respectively, and adenosquamous carcinoma was diagnosed in 0.9%.
  • Numerous lungs with a malignant tumor also showed one or more benign tumor types.
  • In addition, single or multiple metastases from primary tumors of other sites (mainly carcinoma of the uterus) were diagnosed in 14% of the 1002 lungs.
  • The proportionate incidences of the four predominantly diagnosed tumor types were compared with three summarized experimental groups which were exposed either to carbon black (two size classes), to titanium dioxide (two size classes), or to the total of the other nine GBP.
  • [MeSH-major] Adenoma / chemically induced. Air Pollutants / toxicity. Carcinoma / chemically induced. Dust. Lung Neoplasms / chemically induced

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • Hazardous Substances Data Bank. Aluminum oxide .
  • Hazardous Substances Data Bank. TITANIUM DIOXIDE .
  • Hazardous Substances Data Bank. TITANIUM .
  • Hazardous Substances Data Bank. CARBON .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Exp Toxicol Pathol. 2007 Aug;58(6):407; author reply 409 [17560773.001]
  • (PMID = 16806863.001).
  • [ISSN] 0940-2993
  • [Journal-full-title] Experimental and toxicologic pathology : official journal of the Gesellschaft für Toxikologische Pathologie
  • [ISO-abbreviation] Exp. Toxicol. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Air Pollutants; 0 / Aluminum Silicates; 0 / Dust; 15FIX9V2JP / titanium dioxide; 7440-44-0 / Carbon; 7631-86-9 / Silicon Dioxide; D1JT611TNE / Titanium; LMI26O6933 / Aluminum Oxide
  •  go-up   go-down


40. Dominical VM, Cavellani CL, Rocha LP, Corrêa RR, Pereira Gde A, Teixeira Vde P: Chagas disease and gynecologic neoplasias. Ann Diagn Pathol; 2010 Oct;14(5):337-40
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Chagas disease and gynecologic neoplasias.
  • The objective was to determine the occurrence of gynecologic neoplasia (GN) and demographic characteristics in patients with Chagas disease (CD).
  • The most common benign neoplasm was uterine leiomyoma, and malignant, carcinoma of the cervix.
  • [MeSH-major] Carcinoma / pathology. Chagas Disease / pathology. Leiomyoma / pathology. Trypanosoma cruzi. Uterine Cervical Neoplasms / pathology. Uterine Neoplasms / pathology


41. Piekutowski K, Makarewicz R, Zachara BA: The antioxidative role of selenium in pathogenesis of cancer of the female reproductive system. Neoplasma; 2007;54(5):374-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Therefore, the aim of our present study was to compare the selenium status and GSH-Px activity in the plasma of 22 healthy women, 50 individuals suffering from cancer of uterine cervix, uterine corpus or ovary, and 49 women diagnosed with benign neoplasia of the uterine corpus or ovary.
  • In addition, the selenium concentration was measured in postoperative cancer tissues, benign tumors, and histopatologically healthy surgical margins of the aforementioned patients.
  • An average selenium concentration and GSH-Px activity in blood plasma of cancer patients and benign neoplasia patients was significantly lower than in the plasma of healthy women.
  • Postoperative tissues of patients revealed significantly higher selenium concentrations in cancer tissues of uterine cervix and corpus, and benign tumors of uterine corpus, as compared to corresponding healthy tissue margins.
  • Higher accumulation of selenium in these neoplastic tissues might reflect a compensatory up-regulation of antioxidant defense systems in tumors that often undergo a persistent oxidative stress.
  • [MeSH-major] Antioxidants / pharmacology. Genital Neoplasms, Female / physiopathology. Selenium / pharmacology

  • MedlinePlus Health Information. consumer health - Antioxidants.
  • Hazardous Substances Data Bank. SELENIUM, ELEMENTAL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17688366.001).
  • [ISSN] 0028-2685
  • [Journal-full-title] Neoplasma
  • [ISO-abbreviation] Neoplasma
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Slovakia
  • [Chemical-registry-number] 0 / Antioxidants; 0 / Reactive Oxygen Species; H6241UJ22B / Selenium
  •  go-up   go-down


42. Goufman EI, Moshkovskii SA, Tikhonova OV, Lokhov PG, Zgoda VG, Serebryakova MV, Toropygin IY, Vlasova MA, Safarova MR, Makarov OV, Archakov AI: Two-dimensional electrophoretic proteome study of serum thermostable fraction from patients with various tumor conditions. Biochemistry (Mosc); 2006 Apr;71(4):354-60
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Two-dimensional electrophoretic proteome study of serum thermostable fraction from patients with various tumor conditions.
  • The thermostable fraction of serum samples from patients with ovarian, uterus, and breast cancers and benign ovarian tumor was analyzed using two-dimensional electrophoresis combined with MALDI-TOF(-TOF)-mass spectrometry.
  • Apolipoprotein A-I forms have decreased spot volumes, while haptoglobin alpha1, in contrast, is elevated in several tumors.
  • [MeSH-major] Biomarkers, Tumor / blood. Electrophoresis, Gel, Two-Dimensional / methods. Neoplasm Proteins / blood. Proteome / analysis. Proteomics / methods
  • [MeSH-minor] Adult. Aged. Breast Neoplasms / blood. Breast Neoplasms / metabolism. Female. Humans. Middle Aged. Ovarian Neoplasms / blood. Ovarian Neoplasms / metabolism. Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization. Uterine Neoplasms / blood. Uterine Neoplasms / metabolism

  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16615854.001).
  • [ISSN] 0006-2979
  • [Journal-full-title] Biochemistry. Biokhimii︠a︡
  • [ISO-abbreviation] Biochemistry Mosc.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Neoplasm Proteins; 0 / Proteome
  •  go-up   go-down


43. Chu PW, Liu JY, Peng YJ, Yu MH: Solitary fibrous tumor of the uterus. Taiwan J Obstet Gynecol; 2006 Dec;45(4):350-2
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Solitary fibrous tumor of the uterus.
  • OBJECTIVE: A solitary fibrous tumor is an uncommon soft-tissue tumor and rarely occurs in the uterus.
  • CASE REPORT: A 78-year-old woman presented with low abdominal pain, and pelvic computed tomography showed a pelvic mass attached to the uterus.
  • The results of frozen section showed benign mesothelioma-like tumor.
  • Unexpectedly, further histopathologic results of the lesion revealed a solitary fibrous tumor, an outcome that was subsequently confirmed by means of CD34 immunohistochemical stain.
  • CONCLUSION: The behavior of solitary fibrous tumors arising from the uterus is difficult to evaluate; therefore, complete surgical excision featuring clear margins and comprehensive follow-up is recommended.
  • [MeSH-major] Neoplasms, Fibrous Tissue / diagnosis. Uterine Neoplasms / diagnosis
  • [MeSH-minor] Abdominal Pain / etiology. Aged. Antigens, CD34 / analysis. Biomarkers, Tumor / analysis. Female. Humans

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17175498.001).
  • [ISSN] 1875-6263
  • [Journal-full-title] Taiwanese journal of obstetrics & gynecology
  • [ISO-abbreviation] Taiwan J Obstet Gynecol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Antigens, CD34; 0 / Biomarkers, Tumor
  •  go-up   go-down


44. Gökaslan H, Türkeri L, Kavak ZN, Eren F, Sişmanoğlu A, Ilvan S, Durmuşoğlu F: Differential diagnosis of smooth muscle tumors utilizing p53, pTEN and Ki-67 expression with estrogen and progesterone receptors. Gynecol Obstet Invest; 2005;59(1):36-40
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Differential diagnosis of smooth muscle tumors utilizing p53, pTEN and Ki-67 expression with estrogen and progesterone receptors.
  • BACKGROUND/AIM: To investigate the expression and value for diagnosis of the genes, p53 and pTEN, the protein, Ki-67, and the receptors, estrogen and progesterone, in differentiating smooth muscle tumors of the uterus.
  • MATERIAL AND METHOD: Seventeen samples of leiomyosarcoma, 2 smooth muscle tumors with uncertain malignant potential (STUMP), 9 atypical myomas and 15 leiomyomas were stained immunohistochemically.
  • RESULTS: The malignant side of the spectrum was strongly stained for Ki-67 and p53 while uniformly decreasing toward the benign tumors.
  • The staining for progesterone receptor was also statistically significant, but the tumors that were considered benign, such as leiomyoma and atypical myoma, were the ones strongly stained (p = 0.005).
  • The expression of estrogen receptor was significant in these tumors, but the p value was very close to the cut-off value (p = 0.07).
  • As the degree of differentiation of the tumor increased, the trend showed stronger staining for estrogen receptor.
  • However, no difference was detected in the staining properties of the tumors for pTEN (p = 0.2457).
  • CONCLUSION: The expression of Ki-67, p53 and progesterone receptors is promising in immunodifferentiation of smooth muscle tumors of the uterus with malignant potential.
  • [MeSH-major] Biomarkers, Tumor / metabolism. Leiomyosarcoma / diagnosis. Smooth Muscle Tumor / diagnosis. Uterine Neoplasms / diagnosis
  • [MeSH-minor] Female. Humans. Immunohistochemistry / methods. Ki-67 Antigen / metabolism. PTEN Phosphohydrolase. Phosphoric Monoester Hydrolases / metabolism. Predictive Value of Tests. Receptors, Estrogen / metabolism. Receptors, Progesterone / metabolism. Tumor Suppressor Protein p53 / metabolism. Tumor Suppressor Proteins / metabolism

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2005 S. Karger AG, Basel.
  • (PMID = 15377824.001).
  • [ISSN] 0378-7346
  • [Journal-full-title] Gynecologic and obstetric investigation
  • [ISO-abbreviation] Gynecol. Obstet. Invest.
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article
  • [Publication-country] Switzerland
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Ki-67 Antigen; 0 / Receptors, Estrogen; 0 / Receptors, Progesterone; 0 / Tumor Suppressor Protein p53; 0 / Tumor Suppressor Proteins; EC 3.1.3.- / Phosphoric Monoester Hydrolases; EC 3.1.3.48 / PTEN protein, human; EC 3.1.3.67 / PTEN Phosphohydrolase
  •  go-up   go-down


45. Knüsel PR, Kubik-Huch RA, Komminoth R, Siragusa A, Otto RCh: [Ovarian fibrothecoma: MR imaging findings and differential diagnosis]. Praxis (Bern 1994); 2006 Feb 22;95(8):283-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Ovarian fibrothecoma: MR imaging findings and differential diagnosis].
  • [Transliterated title] Fibrothekom des Ovars: MR-bildgebung und Differentialdiagnose.
  • We report the preoperative MR imaging of a 70 year old woman with a large tumor of the lower abdomen.
  • The origin of this tumor was suspected to be either the left ovary or the uterus.
  • In the differential diagnosis a large subserous pedunculated leiomyoma or a low cellular, primarily benign ovarian tumor were considered.
  • [MeSH-major] Fibroma / diagnosis. Magnetic Resonance Imaging. Ovarian Neoplasms / diagnosis. Thecoma / diagnosis
  • [MeSH-minor] Aged. Diagnosis, Differential. Female. Humans. Hysterectomy. Leiomyoma / diagnosis. Neoplasms, Multiple Primary / diagnosis. Ovariectomy. Ovary / pathology. Uterine Neoplasms / diagnosis. Uterus / pathology

  • MedlinePlus Health Information. consumer health - MRI Scans.
  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16523993.001).
  • [ISSN] 1661-8157
  • [Journal-full-title] Praxis
  • [ISO-abbreviation] Praxis (Bern 1994)
  • [Language] ger
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Switzerland
  •  go-up   go-down


46. Dal Cin P: Cytogenetics of Mesenchymal Tumors of the Female Genital Tract. Surg Pathol Clin; 2009 Dec;2(4):813-21
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cytogenetics of Mesenchymal Tumors of the Female Genital Tract.
  • A great diversity of chromosome alterations have been reported in mesenchymal tumors of the female genital tract, particularly in the uterus.
  • Some of these alterations specifically identify a certain tumor type.
  • Cytogenetic studies on benign proliferations have not only demonstrated clonal chromosome changes, but have also pointed out clustering of aberrations to specific chromosome regions.
  • For example, distinct cytogenetic subgroups have been described in uterine leiomyomas with overlapping histologic features.
  • Moreover, such data may give a clue to an understanding of the biologic basis for distinctive behavior of benign versus malignant mesenchymal proliferations.
  • No specific chromosomal abnormalities have been described in malignant mesenchymal tumors, with the exception of low-grade endometrial stromal sarcomas.
  • This article reviews the information currently available on genetic changes in mesenchymal tumors of the female genital tract and, more specifically, those reported in the uterus, where they have been more frequently studied.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2009 Elsevier Inc. All rights reserved.
  • (PMID = 26838780.001).
  • [ISSN] 1875-9181
  • [Journal-full-title] Surgical pathology clinics
  • [ISO-abbreviation] Surg Pathol Clin
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Keywords] NOTNLM ; Chromosomal aberrations / Complex karyotype / FISH / Fusion gene / Translocation
  •  go-up   go-down


47. Plesinac-Karapandzic V, Perisic Z, Milovanovic Z, Vukicevic D, Mileusnic D, Stevanovic J, Rakocevic Z, Saric M: Invasive inflammatory pseudotumor of the pelvis: a case report with review of the literature. J BUON; 2009 Apr-Jun;14(2):301-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Inflammatory pseudotumor (IPT) is a rare benign lesion of unknown etiology, which mimics malignant neoplasm and may arise from various organs.
  • On bimanual vaginal and rectal examination, a mass was involving the uterus, parametria and mostly left adnexa, while the cervix appeared normal.
  • Computed tomographic (CT) scan revealed a 13x10.5 cm mass in the pelvis, mostly at the place of the left adnexa, uterus and both parametria, also involving the surrounding tissues and producing bilateral hydroureteronephrosis.
  • The last follow-up CT, 20 months after laparotomy, revealed no evidence of tumor.
  • [MeSH-major] Granuloma, Plasma Cell / pathology. Pelvic Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19650182.001).
  • [ISSN] 1107-0625
  • [Journal-full-title] Journal of B.U.ON. : official journal of the Balkan Union of Oncology
  • [ISO-abbreviation] J BUON
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Greece
  •  go-up   go-down


48. Kiuru M, Lehtonen R, Eerola H, Aittomäki K, Blomqvist C, Nevanlinna H, Aaltonen LA, Launonen V: No germline FH mutations in familial breast cancer patients. Eur J Hum Genet; 2005 Apr;13(4):506-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Fumarate hydratase: (FH) was recently identified as the predisposing gene for a tumor predisposition syndrome, hereditary leiomyomatosis and renal cell cancer (HLRCC) (MIM 605839).
  • In HLRCC, individuals with a germline heterozygous mutation in the FH gene typically develop benign leiomyomas of the skin and the uterus (fibroids, myomas).
  • In a subset of the families, predisposition to renal cell carcinoma and uterine leiomyosarcoma occurs.
  • [MeSH-major] Breast Neoplasms / genetics. Fumarate Hydratase / genetics. Genetic Predisposition to Disease. Germ-Line Mutation / genetics

  • Genetic Alliance. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • SciCrunch. OMIM: Data: Gene Annotation .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15523491.001).
  • [ISSN] 1018-4813
  • [Journal-full-title] European journal of human genetics : EJHG
  • [ISO-abbreviation] Eur. J. Hum. Genet.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] EC 4.2.1.2 / Fumarate Hydratase
  •  go-up   go-down


49. Skubitz KM, Manivel JC: Giant cell tumor of the uterus: case report and response to chemotherapy. BMC Cancer; 2007;7:46
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Giant cell tumor of the uterus: case report and response to chemotherapy.
  • BACKGROUND: Giant cell tumor (GCT) is usually a benign but locally aggressive primary bone neoplasm in which monocytic macrophage/osteoclast precursor cells and multinucleated osteoclast-like giant cells infiltrate the tumor.
  • The etiology of GCT is unknown, however the tumor cells of GCT have been reported to produce chemoattractants that can attract osteoclasts and osteoclast precursors.
  • CASE PRESENTATION: We report a case of an aggressive GCT of the uterus with rapidly growing lung metastases, and its response to chemotherapy with pegylated-liposomal doxorubicin, ifosfamide, and bevacizumab, along with a review of the literature.
  • CONCLUSION: Aggressive metastasizing GCT may arise in the uterus, and may respond to combination chemotherapy.
  • [MeSH-major] Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Giant Cell Tumors / drug therapy. Uterine Neoplasms / drug therapy
  • [MeSH-minor] Angiogenesis Inhibitors / administration & dosage. Antibiotics, Antineoplastic / administration & dosage. Antibodies, Monoclonal / administration & dosage. Antibodies, Monoclonal, Humanized. Antineoplastic Agents, Alkylating / administration & dosage. Bevacizumab. Combined Modality Therapy. Doxorubicin / administration & dosage. Female. Humans. Hysterectomy. Ifosfamide / administration & dosage. Lung Neoplasms / diagnosis. Lung Neoplasms / drug therapy. Lung Neoplasms / secondary. Middle Aged. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. DOXORUBICIN .
  • Hazardous Substances Data Bank. IFOSFAMIDE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] AJR Am J Roentgenol. 1992 Feb;158(2):331-4 [1729794.001]
  • [Cites] APMIS Suppl. 1991;23:113-8 [1883635.001]
  • [Cites] Cancer. 1993 Nov 15;72(10):2963-9 [8221562.001]
  • [Cites] Clin Orthop Relat Res. 1994 May;(302):219-30 [8168305.001]
  • [Cites] Am J Clin Oncol. 1995 Apr;18(2):144-8 [7900706.001]
  • [Cites] Pathol Int. 1996 Sep;46(9):656-60 [8905874.001]
  • [Cites] Clin Orthop Relat Res. 1997 Feb;(335):253-61 [9020226.001]
  • [Cites] J Clin Oncol. 1997 Jun;15(6):2378-84 [9196153.001]
  • [Cites] Cell. 1998 Apr 17;93(2):165-76 [9568710.001]
  • [Cites] Surg Neurol. 1998 May;49(5):547-52 [9586934.001]
  • [Cites] J Cell Biochem. 1998 Jul 1;70(1):121-9 [9632113.001]
  • [Cites] J Clin Oncol. 1998 Jul;16(7):2445-51 [9667262.001]
  • [Cites] Int Orthop. 1998;22(3):200-4 [9728318.001]
  • [Cites] Pediatrics. 1999 Jun;103(6 Pt 1):1282-3 [10353942.001]
  • [Cites] Rev Chir Orthop Reparatrice Appar Mot. 1999 Jun;85(3):293-6 [10422135.001]
  • [Cites] J Exp Med. 1999 Jul 19;190(2):293-8 [10432291.001]
  • [Cites] J Cancer Res Clin Oncol. 1999 Oct;125(10):577-81 [10473871.001]
  • [Cites] Cancer. 2005 Jul 15;104(2):361-6 [15948172.001]
  • [Cites] J Clin Oncol. 2001 Aug 1;19(15):3483-9 [11481354.001]
  • [Cites] Am J Clin Pathol. 2002 Feb;117(2):210-6 [11863217.001]
  • [Cites] Cancer. 2002 Jun 15;94(12):3225-9 [12115355.001]
  • [Cites] Clin Orthop Relat Res. 2002 Aug;(401):202-8 [12151897.001]
  • [Cites] J Oral Maxillofac Surg. 2002 Oct;60(10):1103-11; discussion 1111-3 [12378481.001]
  • [Cites] Cancer Invest. 2003 Apr;21(2):167-76 [12743981.001]
  • [Cites] Life Sci. 2003 Aug 1;73(11):1427-36 [12850503.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2003 Sep 1;57(1):158-65 [12909228.001]
  • [Cites] Br J Surg. 2004 Feb;91(2):242-7 [14760675.001]
  • [Cites] Orthopade. 2004 Mar;33(3):344-8 [15007559.001]
  • [Cites] Skeletal Radiol. 2004 May;33(5):295-9 [14997349.001]
  • [Cites] J Lab Clin Med. 2004 Aug;144(2):78-91 [15322502.001]
  • [Cites] Clin Orthop Relat Res. 2004 Sep;(426):32-8 [15346048.001]
  • [Cites] Clin Orthop Relat Res. 2004 Sep;(426):103-9 [15346059.001]
  • [Cites] Clin Cancer Res. 2004 Sep 1;10(17):5732-40 [15355900.001]
  • [Cites] Calcif Tissue Int. 2004 Jul;75(1):71-7 [15037971.001]
  • [Cites] J Lab Clin Med. 2004 Oct;144(4):193-200 [15514587.001]
  • [Cites] Cancer. 1968 Aug;22(2):333-44 [5660199.001]
  • [Cites] Endocrinology. 1972 Oct;91(4):916-20 [5051344.001]
  • [Cites] Cancer. 1973 Mar;31(3):621-5 [4693590.001]
  • [Cites] Cancer. 1975 Aug;36(2):495-504 [50874.001]
  • [Cites] Science. 1975 Nov 21;190(4216):784-5 [1105786.001]
  • [Cites] Virchows Arch A Pathol Anat Histol. 1976 Sep 21;371(3):199-217 [184582.001]
  • [Cites] Acta Pathol Microbiol Scand A. 1981 Mar;89(2):179-84 [7270164.001]
  • [Cites] Cancer. 1981 Nov 1;48(9):2022-8 [7296510.001]
  • [Cites] Arkh Patol. 1983;45(2):78-82 [6847417.001]
  • [Cites] J Bone Joint Surg Am. 1985 Jul;67(6):890-900 [4019539.001]
  • [Cites] Nature. 1999 Nov 18;402(6759):304-9 [10580503.001]
  • [Cites] Am J Pathol. 2000 Mar;156(3):761-7 [10702390.001]
  • [Cites] J Bone Miner Res. 2000 Apr;15(4):640-9 [10780856.001]
  • [Cites] Hum Pathol. 2000 Jul;31(7):804-12 [10923916.001]
  • [Cites] Eur J Cancer. 2001 May;37(7):870-7 [11313175.001]
  • [Cites] J Pathol. 1985 Nov;147(3):153-8 [4067733.001]
  • [Cites] Gynecol Oncol. 1986 Mar;23(3):381-6 [3957125.001]
  • [Cites] J Clin Invest. 1987 Feb;79(2):483-91 [3027126.001]
  • [Cites] Clin Orthop Relat Res. 1988 Dec;(237):275-85 [3056645.001]
  • [Cites] Clin Orthop Relat Res. 1989 Jun;(243):208-15 [2656024.001]
  • [Cites] Cancer. 1990 Apr 15;65(8):1838-42 [2317762.001]
  • [Cites] J Cancer Res Clin Oncol. 1993;119(5):301-3 [8440744.001]
  • (PMID = 17359524.001).
  • [ISSN] 1471-2407
  • [Journal-full-title] BMC cancer
  • [ISO-abbreviation] BMC Cancer
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Angiogenesis Inhibitors; 0 / Antibiotics, Antineoplastic; 0 / Antibodies, Monoclonal; 0 / Antibodies, Monoclonal, Humanized; 0 / Antineoplastic Agents, Alkylating; 2S9ZZM9Q9V / Bevacizumab; 80168379AG / Doxorubicin; UM20QQM95Y / Ifosfamide
  • [Number-of-references] 57
  • [Other-IDs] NLM/ PMC1832205
  •  go-up   go-down


50. Arora R, Abou-Bakr AA, Ahmad MS: Intravenous leiomyomatosis of the uterus. Gulf J Oncolog; 2010 Jan;(7):57-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Intravenous leiomyomatosis of the uterus.
  • Intravenous leiomyomatosis (IVL) is a rare neoplasm characterized by nodular masses of histologically benign looking smooth muscle cells growing within uterine or extrauterine venous system.The exact etiology is unclear and benign histological appearance of neoplastic smooth muscles can be deceptive since IVL might behave in a malignant fashion.
  • Total abdominal hysterectomy and excision of any extrauterine tumor if technically feasible is the cornerstone of treatment.
  • We report clinical, histological, and immunohistochemical features of a uterine IVL in a 48 year old lady who presented with menorrhagia.
  • We also elaborate etiopathogenesis and conclude that knowledge about IVL is essential as it must be differentiated from malignant tumors to prevent overtreatment.
  • [MeSH-major] Leiomyomatosis / pathology. Uterine Neoplasms / pathology. Vascular Neoplasms / pathology. Veins / pathology

  • Genetic Alliance. consumer health - Intravenous leiomyomatosis.
  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20164011.001).
  • [ISSN] 2078-2101
  • [Journal-full-title] The Gulf journal of oncology
  • [ISO-abbreviation] Gulf J Oncolog
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Kuwait
  •  go-up   go-down


51. Ohmaru T, Yamakawa H, Netsu S, Nokubi M, Konno R: Placental site trophoblastic tumor (PSTT) with multiple metastases and extremely poor prognosis. Int J Clin Oncol; 2009 Oct;14(5):452-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Placental site trophoblastic tumor (PSTT) with multiple metastases and extremely poor prognosis.
  • Placental site trophoblastic tumor (PSTT) is a rare type of gestational trophoblastic disease.
  • There is a wide clinical spectrum of presentation and behavior ranging from a benign condition to an aggressive disease with a fatal outcome.
  • PSTT limited to the uterus is in a good prognosis group, but PSTT with metastasis is a lethal disease.
  • The mitotic count of the tumor cells was quite high (23/10 high-power fields).
  • It would have been difficult to remove the tumor by surgery because of the tumor size and its invasion, so we suggested chemotherapy.
  • [MeSH-major] Trophoblastic Tumor, Placental Site / secondary. Uterine Neoplasms / secondary
  • [MeSH-minor] Adult. Antineoplastic Combined Chemotherapy Protocols / administration & dosage. Biopsy. Cell Differentiation. Cyclophosphamide / administration & dosage. Dactinomycin / administration & dosage. Drug Resistance, Neoplasm. Etoposide / administration & dosage. Fatal Outcome. Female. Humans. Magnetic Resonance Imaging. Methotrexate / administration & dosage. Mitotic Index. Neoplasm Invasiveness. Pregnancy. Tomography, X-Ray Computed. Treatment Failure. Vincristine / administration & dosage

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • Hazardous Substances Data Bank. ETOPOSIDE .
  • Hazardous Substances Data Bank. CYCLOPHOSPHAMIDE .
  • Hazardous Substances Data Bank. DACTINOMYCIN .
  • Hazardous Substances Data Bank. VINCRISTINE .
  • Hazardous Substances Data Bank. METHOTREXATE .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Gynecol Oncol. 1999 May;73(2):216-22 [10329037.001]
  • [Cites] Gynecol Oncol. 1988 Sep;31(1):32-42 [2842238.001]
  • [Cites] Eur J Gynaecol Oncol. 1995;16(4):290-5 [7556286.001]
  • [Cites] Am J Surg Pathol. 1981 Jan;5(1):75-6 [6264815.001]
  • [Cites] Gynecol Oncol. 2006 Mar;100(3):511-20 [16246400.001]
  • [Cites] Gynecol Oncol. 2001 Sep;82(3):415-9 [11520134.001]
  • [Cites] Obstet Gynecol Surv. 2003 Jul;58(7):484-8 [12832940.001]
  • [Cites] Gynecol Oncol. 2005 Dec;99(3):603-7 [16085293.001]
  • [Cites] Gynecol Oncol. 1981 Oct;12(2 Pt 1):238-48 [6271654.001]
  • [Cites] Gynecol Oncol. 1998 Jan;68(1):62-5 [9454662.001]
  • [Cites] Int J Gynecol Cancer. 2007 Jan-Feb;17(1):258-62 [17291263.001]
  • [Cites] Placenta. 1984 Jul-Aug;5(4):349-69 [6209706.001]
  • [Cites] J Reprod Med. 2002 Jun;47(6):460-4 [12092014.001]
  • [Cites] Cancer. 1976 Sep;38(3):1214-26 [182351.001]
  • [Cites] Gynecol Oncol. 2004 May;93(2):550-3 [15099979.001]
  • [Cites] Gynecol Oncol. 1999 Oct;75(1):164-9 [10502447.001]
  • [Cites] J Clin Oncol. 2000 Feb;18(4):854-9 [10673528.001]
  • (PMID = 19856056.001).
  • [ISSN] 1437-7772
  • [Journal-full-title] International journal of clinical oncology
  • [ISO-abbreviation] Int. J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 1CC1JFE158 / Dactinomycin; 5J49Q6B70F / Vincristine; 6PLQ3CP4P3 / Etoposide; 8N3DW7272P / Cyclophosphamide; YL5FZ2Y5U1 / Methotrexate; EMA-CO protocol
  •  go-up   go-down


52. Bagga R, Keepanasseril A, Srinivasan R, Dey P, Gainder S, Saha SC, Dhaliwal LK, Patel F: Adenosarcoma of the uterine cervix with heterologous elements: a case report and review of literature. Arch Gynecol Obstet; 2010 Apr;281(4):669-75
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adenosarcoma of the uterine cervix with heterologous elements: a case report and review of literature.
  • INTRODUCTION: Adenosarcoma of the uterus is a rare tumor composed of benign epithelial and malignant stromal components, usually encountered in young women.
  • MATERIALS AND METHODS: We describe a case of mullerian adenosarcoma with heterologous elements of rhabdomyosarcoma and benign cartilage presenting as a cervical polyp in a young girl.
  • CONCLUSION: Cervical adenosarcomas are rare tumors that may appear in reproductive age.
  • [MeSH-major] Adenosarcoma / pathology. Cervix Uteri / pathology. Uterine Cervical Neoplasms / pathology


53. Nierth-Simpson EN, Martin MM, Chiang TC, Melnik LI, Rhodes LV, Muir SE, Burow ME, McLachlan JA: Human uterine smooth muscle and leiomyoma cells differ in their rapid 17beta-estradiol signaling: implications for proliferation. Endocrinology; 2009 May;150(5):2436-45
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Human uterine smooth muscle and leiomyoma cells differ in their rapid 17beta-estradiol signaling: implications for proliferation.
  • Uterine leiomyomas, benign uterine smooth muscle tumors that affect 30% of reproductive-aged women, are a significant health concern.
  • The initiation event for these tumors is unclear, but 17beta-estradiol (E2) is an established promoter of leiomyoma growth.
  • Western blot analysis revealed that E2 rapidly increases levels of phosphorylated protein kinase C alpha (PKC alpha) in both immortalized uterine smooth muscle (UtSM) and leiomyoma (UtLM) cell lines, but increases levels of phosphorylated ERK1/2 only in UtLM cells.
  • We therefore propose a model whereby E2's rapid activation of PKC alpha and cAMP-PKA signaling plays a central role in the maintenance of a low proliferative index in normal uterine smooth muscle via its inhibition of the MAPK cascade and these pathways are altered in leiomyomas to promote MAPK activation and proliferation.

  • Genetic Alliance. consumer health - Uterine Fibroid.
  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • MedlinePlus Health Information. consumer health - Uterine Fibroids.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. ESTRADIOL .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Mol Hum Reprod. 1998 Jan;4(1):83-6 [9510016.001]
  • [Cites] J Cell Physiol. 1998 Aug;176(2):435-44 [9648931.001]
  • [Cites] Epidemiology. 1998 Sep;9(5):511-7 [9730029.001]
  • [Cites] Fertil Steril. 1998 Sep;70(3):432-9 [9757871.001]
  • [Cites] Endocrinology. 1998 Nov;139(11):4598-606 [9794471.001]
  • [Cites] Baillieres Clin Obstet Gynaecol. 1998 Jun;12(2):177-95 [10023417.001]
  • [Cites] Am J Physiol. 1999 Mar;276(3 Pt 1):E503-11 [10070017.001]
  • [Cites] Am J Physiol. 1999 Jun;276(6 Pt 1):E1112-8 [10362625.001]
  • [Cites] Cancer Genet Cytogenet. 1999 Oct 1;114(1):9-16 [10526529.001]
  • [Cites] Am J Obstet Gynecol. 2004 Nov;191(5):1621-31 [15547533.001]
  • [Cites] J Exp Clin Cancer Res. 2004 Sep;23(3):385-94 [15595626.001]
  • [Cites] J Cell Physiol. 2005 Apr;203(1):193-201 [15389627.001]
  • [Cites] Genes Cells. 2005 Mar;10(3):225-39 [15743412.001]
  • [Cites] Reprod Toxicol. 2005 May-Jun;20(1):81-4 [15808789.001]
  • [Cites] Steroids. 2005 May-Jun;70(5-7):361-3 [15862818.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Jun 14;102(24):8644-9 [15937110.001]
  • [Cites] Mol Hum Reprod. 2005 Jun;11(6):441-50 [15879465.001]
  • [Cites] Mol Endocrinol. 2005 Aug;19(8):1951-9 [15705661.001]
  • [Cites] Mol Endocrinol. 2006 Mar;20(3):491-502 [16306086.001]
  • [Cites] Biol Reprod. 2006 May;74(5):839-49 [16407500.001]
  • [Cites] Cancer Lett. 2006 Jul 8;238(1):1-14 [16084012.001]
  • [Cites] Hum Reprod Update. 2006 Jul-Aug;12(4):385-400 [16603566.001]
  • [Cites] Fertil Steril. 2006 Sep;86(3):686-93 [16860797.001]
  • [Cites] Cancer Res. 2008 Feb 1;68(3):826-33 [18245484.001]
  • [Cites] Cell Signal. 2008 Sep;20(9):1592-607 [18423978.001]
  • [Cites] Bull Cancer. 1999 Nov;86(11):920-8 [10586108.001]
  • [Cites] Hypertension. 2000 Jan;35(1 Pt 2):262-6 [10642308.001]
  • [Cites] J Biol Chem. 2000 Jun 16;275(24):18447-53 [10749889.001]
  • [Cites] Nature. 1993 Jul 15;364(6434):249-52 [8321321.001]
  • [Cites] Science. 1993 Nov 12;262(5136):1065-9 [7694366.001]
  • [Cites] Science. 1993 Nov 12;262(5136):1069-72 [7694367.001]
  • [Cites] J Soc Gynecol Investig. 2000 Jul-Aug;7(4):249-56 [10964025.001]
  • [Cites] Environ Health Perspect. 2000 Oct;108 Suppl 5:769-73 [11035980.001]
  • [Cites] Biol Reprod. 2000 Nov;63(5):1322-30 [11058535.001]
  • [Cites] Med Hypotheses. 2000 Dec;55(6):485-90 [11090295.001]
  • [Cites] Pharmacol Rev. 2000 Dec;52(4):513-56 [11121509.001]
  • [Cites] Hum Reprod Update. 2001 Jan-Feb;7(1):8-14 [11212080.001]
  • [Cites] J Clin Endocrinol Metab. 2001 Jan;86(1):454-7 [11232041.001]
  • [Cites] Trends Endocrinol Metab. 2001 May-Jun;12(4):152-6 [11295570.001]
  • [Cites] J Clin Endocrinol Metab. 2001 Apr;86(4):1707-15 [11297607.001]
  • [Cites] Gynecol Obstet Invest. 2001;51(3):191-6 [11306908.001]
  • [Cites] J Cell Physiol. 2001 Aug;188(2):170-7 [11424083.001]
  • [Cites] Exp Physiol. 2001 Mar;86(2):265-72 [11429643.001]
  • [Cites] J Appl Physiol (1985). 2001 Oct;91(4):1860-7 [11568173.001]
  • [Cites] Front Biosci. 2001 Oct 1;6:D1379-91 [11578956.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Oct 9;98(21):12267-71 [11572951.001]
  • [Cites] J Clin Endocrinol Metab. 2001 Nov;86(11):5593-9 [11701740.001]
  • [Cites] Biol Reprod. 2002 Jan;66(1):44-9 [11751262.001]
  • [Cites] Carcinogenesis. 2001 Dec;22(12):2049-52 [11751438.001]
  • [Cites] J Endocrinol. 2002 Jan;172(1):83-93 [11786376.001]
  • [Cites] Ann N Y Acad Sci. 2001 Dec;948:112-20 [11795389.001]
  • [Cites] Recent Prog Horm Res. 2002;57:277-94 [12017548.001]
  • [Cites] Lab Invest. 2002 Jun;82(6):719-28 [12065682.001]
  • [Cites] Sci STKE. 2002 Jun 25;2002(138):re9 [12084906.001]
  • [Cites] Fertil Steril. 2002 Jul;78(1):114-21 [12095500.001]
  • [Cites] Virchows Arch. 2002 Jul;441(1):53-62 [12111201.001]
  • [Cites] Toxicol Pathol. 2002 Sep-Oct;30(5):611-6 [12371671.001]
  • [Cites] Trends Endocrinol Metab. 2002 Dec;13(10):422-7 [12431838.001]
  • [Cites] J Biol Chem. 2002 Dec 27;277(52):50768-75 [12372818.001]
  • [Cites] J Soc Gynecol Investig. 2003 Jan;10(1):11-20 [12517588.001]
  • [Cites] Endocrinology. 2003 May;144(5):1812-24 [12697687.001]
  • [Cites] J Lab Clin Med. 2003 May;141(5):297-308 [12761473.001]
  • [Cites] Gynecol Oncol. 2003 Jul;90(1):123-30 [12821352.001]
  • [Cites] IUBMB Life. 2003 Mar;55(3):145-50 [12822891.001]
  • [Cites] Environ Health Perspect. 2003 Jun;111(8):1037-54 [12826476.001]
  • [Cites] Fertil Steril. 2003 Aug;80(2):266-76 [12909484.001]
  • [Cites] Steroids. 2003 Nov;68(10-13):817-24 [14667973.001]
  • [Cites] Int J Exp Pathol. 2003 Dec;84(6):267-79 [14748746.001]
  • [Cites] Hum Reprod. 2004 Apr;19(4):815-21 [15033949.001]
  • [Cites] Genes Chromosomes Cancer. 2004 Jun;40(2):97-108 [15101043.001]
  • [Cites] Genes Chromosomes Cancer. 2004 Jul;40(3):204-17 [15139000.001]
  • [Cites] Hum Reprod Update. 2004 May-Jun;10(3):207-20 [15140868.001]
  • [Cites] Semin Reprod Med. 2004 May;22(2):105-11 [15164305.001]
  • [Cites] Fertil Steril. 2004 Sep;82(3):639-49 [15374708.001]
  • [Cites] Proc Natl Acad Sci U S A. 1967 Oct;58(4):1711-8 [4295833.001]
  • [Cites] Cancer Res. 1980 Nov;40(11):3988-99 [7193511.001]
  • [Cites] Br Med J (Clin Res Ed). 1986 Aug 9;293(6543):359-62 [3730804.001]
  • [Cites] Obstet Gynecol. 1989 Oct;74(4):658-62 [2797644.001]
  • [Cites] Biochem Biophys Res Commun. 1990 Sep 28;171(3):1087-92 [2171506.001]
  • [Cites] Obstet Gynecol. 1991 May;77(5):720-5 [1901638.001]
  • [Cites] Virchows Arch A Pathol Anat Histopathol. 1991;419(4):309-15 [1949613.001]
  • [Cites] Am J Obstet Gynecol. 1992 Jan;166(1 Pt 1):64-9 [1310202.001]
  • [Cites] Biochem J. 1992 Apr 15;283 ( Pt 2):515-8 [1575696.001]
  • [Cites] J Med Chem. 1993 Jan 8;36(1):21-9 [8421286.001]
  • [Cites] Mol Endocrinol. 1993 Mar;7(3):441-52 [7683375.001]
  • [Cites] J Cell Physiol. 1996 Jan;166(1):22-32 [8557771.001]
  • [Cites] Environ Health Perspect. 1995 Oct;103 Suppl 7:35-8 [8593872.001]
  • [Cites] J Endocrinol. 1996 Jan;148(1):175-80 [8568465.001]
  • [Cites] EMBO J. 1996 Mar 15;15(6):1292-300 [8635462.001]
  • [Cites] Eur J Pharmacol. 1996 Oct 17;313(3):257-63 [8911922.001]
  • [Cites] Mol Carcinog. 1996 Nov;17(3):151-9 [8944075.001]
  • [Cites] Br J Cancer. 1997;75(11):1631-40 [9184179.001]
  • [Cites] Endocrinology. 1997 Aug;138(8):3330-9 [9231785.001]
  • [Cites] Mol Hum Reprod. 1996 Nov;2(11):823-8 [9237221.001]
  • [Cites] J Soc Gynecol Investig. 1995 May-Jun;2(3):542-51 [9420857.001]
  • (PMID = 19179429.001).
  • [ISSN] 1945-7170
  • [Journal-full-title] Endocrinology
  • [ISO-abbreviation] Endocrinology
  • [Language] ENG
  • [Grant] United States / NIDDK NIH HHS / DK / R01 DK059389; United States / NIDDK NIH HHS / DK / DK059389
  • [Publication-type] Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 4TI98Z838E / Estradiol
  • [Other-IDs] NLM/ PMC2671893
  •  go-up   go-down


54. Zhang P, Zhang C, Hao J, Sung CJ, Quddus MR, Steinhoff MM, Lawrence WD: Use of X-chromosome inactivation pattern to determine the clonal origins of uterine leiomyoma and leiomyosarcoma. Hum Pathol; 2006 Oct;37(10):1350-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Use of X-chromosome inactivation pattern to determine the clonal origins of uterine leiomyoma and leiomyosarcoma.
  • Uterine leiomyomas (LMs) and leiomyosarcomas (LMSs), both of smooth muscle origin, sometimes coexist in the same uterus.
  • Of the 24 patients with LM, 21 had multiple neoplasms; all were clonal and individual LMs derived from separate clones.
  • Of the 20 patients with LMS, 6 exhibited multiple tumors in the uterus, and 4 of these individuals also harbored coexisting uterine LMs.
  • Separate tumors showed identical pattern of X inactivation in 4 patients, and in 2 other individuals, multiple LMSs developed from independent clones.
  • In 2 of the 3 patients, the tumor also exhibited a morphological transition between benign cells in LM and malignant cells in LMS, supporting the possibility of transformation from LM to LMS.
  • (iv) most LMSs are solitary lesions and are most likely de novo, but an individual LM may undergo "malignant transformation" to a LMS; and (v) some LMSs and coexisting LMs are of independent origins.
  • [MeSH-major] Chromosomes, Human, X. Leiomyoma / genetics. Leiomyosarcoma / genetics. Uterine Neoplasms / genetics. X Chromosome Inactivation
  • [MeSH-minor] Adult. Clone Cells. DNA, Neoplasm / analysis. Female. Humans. Middle Aged. Polymerase Chain Reaction. Receptors, Androgen / genetics


55. Poujade O, Genin AS, Dhouha M, Luton D: A benign metastasizing leiomyoma involving a nodule in the pulmonary artery: case and literature review. Eur J Gynaecol Oncol; 2010;31(3):329-32
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A benign metastasizing leiomyoma involving a nodule in the pulmonary artery: case and literature review.
  • Benign metastasizing leiomyoma (BML) is a rare disease defined as a primary benign uterine tumor with "metastatic" lesions preferentially occurring in the lung, pelvis and lymph nodes.
  • A 55-year-old woman complaining of abdominal discomfort, heaviness and asthenia was admitted to our hospital for investigation of a voluminous uterine mass with high vascularization and three pulmonary nodules.
  • The resection of the mass by laparotomy was complicated by uncontrolled severe hemorrhage due to vascular proliferation, requiring multiple transfusions, packing the cavity and postoperative uterine artery embolization.
  • The comparison of hysterectomy and lobectomy pieces showed a similar aspect, leading thus to the diagnosis of BML.
  • Awareness of this rare entity should potentially avoid under-diagnosis and difficulties due to hemorrhage during surgery.
  • [MeSH-major] Leiomyoma / pathology. Lung Neoplasms / secondary. Pulmonary Artery / pathology. Uterine Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • MedlinePlus Health Information. consumer health - Uterine Fibroids.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21077481.001).
  • [ISSN] 0392-2936
  • [Journal-full-title] European journal of gynaecological oncology
  • [ISO-abbreviation] Eur. J. Gynaecol. Oncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Italy
  •  go-up   go-down


56. Lin CK, Chu TW, Yu MH: Painless ovarian torsion mimicking a uterine myoma. Taiwan J Obstet Gynecol; 2006 Dec;45(4):340-2
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Painless ovarian torsion mimicking a uterine myoma.
  • OBJECTIVE: Uterine myoma is the most common benign solid pelvic tumor seen in women and is easily demonstrated by pelvic ultrasonography.
  • We herein present an unusual case of painless ovarian torsion similar to a subserous uterine myoma.
  • Ultrasound revealed a well-defined, heterogeneous solid mass with echogenic rim that resembled a uterine myoma, 10.9 x 9.9 x 7.3 cm in size, just upon the uterus.
  • Although there may be no specific indication, the diagnosis of ovarian torsion should be considered on finding a pelvic mass.
  • [MeSH-major] Leiomyoma / diagnosis. Ovarian Diseases / diagnosis. Uterine Neoplasms / diagnosis
  • [MeSH-minor] Adult. Diagnosis, Differential. Female. Humans. Torsion Abnormality / diagnosis

  • MedlinePlus Health Information. consumer health - Ovarian Disorders.
  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • MedlinePlus Health Information. consumer health - Uterine Fibroids.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17175495.001).
  • [ISSN] 1875-6263
  • [Journal-full-title] Taiwanese journal of obstetrics & gynecology
  • [ISO-abbreviation] Taiwan J Obstet Gynecol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] China
  •  go-up   go-down


57. Yeh SY, Chao TK: Leiomyoma of the external auditory canal--a case report and brief review of the literature. Eur Arch Otorhinolaryngol; 2005 May;262(5):397-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Leiomyoma usually originates from the uterus and alimentary tract, but rarely from the soft tissue of the head and neck.
  • Tumor excision was successful via a retroauricular approach.
  • The tumor occurs mainly in adult males aged around 50 and should be included in the differential diagnoses for external auditory canal tumor.
  • In case of an external auditory canal tumor, even if it is believed to be benign before surgery, precise pathologic examination is required to exclude the possibility of malignancy.
  • [MeSH-major] Ear Canal / surgery. Ear Neoplasms / diagnosis. Ear Neoplasms / surgery. Leiomyoma / diagnosis. Leiomyoma / surgery
  • [MeSH-minor] Audiometry, Pure-Tone. Diagnosis, Differential. Hearing Loss, Conductive / etiology. Humans. Immunohistochemistry. Male. Middle Aged. Otologic Surgical Procedures. Otoscopy. Tomography, X-Ray Computed. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Acta Pathol Jpn. 1979 May;29(3):389-408 [222115.001]
  • [Cites] Am J Otol. 1996 Jan;17(1):133-6 [8694117.001]
  • [Cites] Cancer. 1975 May;35(5):1300-8 [1122481.001]
  • [Cites] Laryngoscope. 1975 May;85(5):904-10 [1142965.001]
  • [Cites] Plast Reconstr Surg. 1988 Feb;81(2):264-9 [3275946.001]
  • [Cites] Arch Pathol. 1959 Oct;68:424-30 [13818517.001]
  • [Cites] Cancer. 1958 Jul-Aug;11(4):844-54 [13561254.001]
  • [Cites] Otolaryngol Head Neck Surg. 1997 Feb;116(2):231-3 [9051070.001]
  • (PMID = 15368068.001).
  • [ISSN] 0937-4477
  • [Journal-full-title] European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
  • [ISO-abbreviation] Eur Arch Otorhinolaryngol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Germany
  • [Number-of-references] 8
  •  go-up   go-down


58. Luo X, Chegini N: The expression and potential regulatory function of microRNAs in the pathogenesis of leiomyoma. Semin Reprod Med; 2008 Nov;26(6):500-14
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Leiomyomas are benign uterine tumors considered to arise from transformation of myometrial cells.

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • MedlinePlus Health Information. consumer health - Uterine Fibroids.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Stem Cells. 2008 Feb;26(2):356-63 [17991914.001]
  • [Cites] J Cell Mol Med. 2008 Jan-Feb;12(1):227-40 [18182067.001]
  • [Cites] Hum Gene Ther. 2008 Jan;19(1):17-26 [18211225.001]
  • [Cites] J Biol Chem. 2008 Apr 11;283(15):9836-43 [18281287.001]
  • [Cites] Obstet Gynecol. 2008 May;111(5):1129-36 [18448745.001]
  • [Cites] Int J Biochem Cell Biol. 2008;40(6-7):1068-78 [18243766.001]
  • [Cites] Fertil Steril. 2008 Jun;89(6):1771-6 [17765232.001]
  • [Cites] Cell Signal. 2008 Aug;20(8):1409-14 [18296024.001]
  • [Cites] Semin Reprod Med. 2008 Jul;26(4):298-312 [18756407.001]
  • [Cites] Environ Health Perspect. 2000 Oct;108 Suppl 5:785-90 [11035983.001]
  • [Cites] J Clin Endocrinol Metab. 2001 Apr;86(4):1707-15 [11297607.001]
  • [Cites] Clin Obstet Gynecol. 2001 Jun;44(2):327-34 [11344996.001]
  • [Cites] Front Biosci. 2002 Apr 1;7:e91-115 [11897550.001]
  • [Cites] Oncogene. 2002 May 2;21(19):2971-80 [12082527.001]
  • [Cites] Fertil Steril. 2002 Jul;78(1):114-21 [12095500.001]
  • [Cites] Mol Hum Reprod. 2002 Dec;8(12):1071-8 [12468639.001]
  • [Cites] Mol Hum Reprod. 2003 Sep;9(9):541-9 [12900513.001]
  • [Cites] Cell. 2004 Jan 23;116(2):281-97 [14744438.001]
  • [Cites] Int J Exp Pathol. 2003 Dec;84(6):267-79 [14748746.001]
  • [Cites] Genes Chromosomes Cancer. 2004 Jun;40(2):97-108 [15101043.001]
  • [Cites] Hum Reprod Update. 2004 May-Jun;10(3):207-20 [15140868.001]
  • [Cites] Semin Reprod Med. 2004 May;22(2):83-90 [15164303.001]
  • [Cites] Semin Reprod Med. 2004 May;22(2):91-103 [15164304.001]
  • [Cites] Am J Physiol Cell Physiol. 2004 Oct;287(4):C1012-22 [15201140.001]
  • [Cites] Am J Obstet Gynecol. 1989 Mar;160(3):637-41 [2929683.001]
  • [Cites] Mol Hum Reprod. 1997 May;3(5):411-8 [9239726.001]
  • [Cites] Baillieres Clin Obstet Gynaecol. 1998 Jun;12(2):225-43 [10023420.001]
  • [Cites] J Clin Endocrinol Metab. 2004 Nov;89(11):5549-57 [15531510.001]
  • [Cites] Nat Genet. 2006 Sep;38(9):1060-5 [16878133.001]
  • [Cites] Cancer Res. 2006 Sep 15;66(18):9090-8 [16982751.001]
  • [Cites] J Clin Oncol. 2006 Oct 10;24(29):4677-84 [16966691.001]
  • [Cites] Oncogene. 2006 Oct 9;25(46):6156-62 [17028594.001]
  • [Cites] Oncogene. 2006 Oct 9;25(46):6163-9 [17028595.001]
  • [Cites] Oncogene. 2006 Oct 9;25(46):6176-87 [17028597.001]
  • [Cites] Oncogene. 2006 Oct 9;25(46):6202-10 [17028600.001]
  • [Cites] Blood. 2006 Nov 1;108(9):3068-71 [16849646.001]
  • [Cites] Steroids. 2006 Nov;71(11-12):960-5 [16935316.001]
  • [Cites] Nat Rev Cancer. 2006 Nov;6(11):857-66 [17060945.001]
  • [Cites] Childs Nerv Syst. 2006 Nov;22(11):1419-25 [16983573.001]
  • [Cites] J Cell Sci. 2006 Dec 1;119(Pt 23):4803-10 [17130294.001]
  • [Cites] Nucleic Acids Res. 2006;34(20):5863-71 [17062625.001]
  • [Cites] PLoS One. 2006;1:e116 [17205120.001]
  • [Cites] J Appl Physiol (1985). 2007 Jan;102(1):306-13 [17008435.001]
  • [Cites] Nucleic Acids Res. 2007;35(1):152-64 [17158157.001]
  • [Cites] J Biol Chem. 2007 Jan 26;282(4):2135-43 [17135249.001]
  • [Cites] Proc Natl Acad Sci U S A. 2007 Jan 30;104(5):1604-9 [17242365.001]
  • [Cites] Genes Chromosomes Cancer. 2007 Apr;46(4):336-47 [17243163.001]
  • [Cites] J Invest Dermatol. 2007 Mar;127(3):526-37 [17299435.001]
  • [Cites] Circ Res. 2007 Feb 16;100(3):416-24 [17234972.001]
  • [Cites] Genes Dev. 2007 Mar 1;21(5):578-89 [17344418.001]
  • [Cites] Mol Endocrinol. 2007 May;21(5):1132-47 [17312270.001]
  • [Cites] Oncogene. 2007 Apr 26;26(19):2799-803 [17072344.001]
  • [Cites] Science. 2007 Apr 27;316(5824):608-11 [17463290.001]
  • [Cites] DNA Cell Biol. 2007 Apr;26(4):195-207 [17465886.001]
  • [Cites] Genomics. 2007 Jun;89(6):687-96 [17418524.001]
  • [Cites] Am J Pathol. 2007 Jun;170(6):1807-16 [17525249.001]
  • [Cites] J Mol Cell Cardiol. 2007 Jun;42(6):1137-41 [17498736.001]
  • [Cites] Circ Res. 2007 Jun 8;100(11):1579-88 [17478730.001]
  • [Cites] Nat Cell Biol. 2007 Jul;9(7):775-87 [17589498.001]
  • [Cites] Circ Res. 2007 Jul 6;101(1):59-68 [17540974.001]
  • [Cites] Mol Cell. 2007 Jul 6;27(1):91-105 [17612493.001]
  • [Cites] Biochem Soc Trans. 2007 Aug;35(Pt 4):661-4 [17635115.001]
  • [Cites] Cancer Res. 2007 Aug 15;67(16):7713-22 [17699775.001]
  • [Cites] Genes Dev. 2007 Aug 15;21(16):1999-2004 [17626790.001]
  • [Cites] Best Pract Res Clin Haematol. 2007 Sep;20(3):425-37 [17707831.001]
  • [Cites] PLoS Genet. 2007 Aug;3(8):e146 [17784791.001]
  • [Cites] J Cell Biochem. 2007 Oct 15;102(3):593-608 [17729308.001]
  • [Cites] J Immunol. 2007 Oct 15;179(8):5082-9 [17911593.001]
  • [Cites] Reprod Biol Endocrinol. 2007;5:35 [17718906.001]
  • [Cites] Nat Rev Mol Cell Biol. 2007 Nov;8(11):857-69 [17895899.001]
  • [Cites] Nat Rev Cancer. 2007 Nov;7(11):819-22 [17914404.001]
  • [Cites] Reprod Biol Endocrinol. 2007;5:34 [17716379.001]
  • [Cites] Genes Chromosomes Cancer. 2008 Jan;47(1):56-63 [17943974.001]
  • [Cites] Endocrinology. 2005 Mar;146(3):1074-96 [15604208.001]
  • [Cites] Endocrinology. 2005 Mar;146(3):1097-118 [15604209.001]
  • [Cites] Obstet Gynecol. 2005 Mar;105(3):563-8 [15738025.001]
  • [Cites] Semin Immunol. 2005 Apr;17(2):155-65 [15737576.001]
  • [Cites] PLoS Biol. 2005 Mar;3(3):e85 [15723116.001]
  • [Cites] Endocr Rev. 2005 May;26(3):423-38 [15857972.001]
  • [Cites] Science. 2005 Jun 10;308(5728):1589-92 [15947177.001]
  • [Cites] Mol Hum Reprod. 2005 Jul;11(7):489-94 [16123076.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Sep 27;102(39):13944-9 [16166262.001]
  • [Cites] Hum Reprod. 2006 Jan;21(1):57-67 [16172143.001]
  • [Cites] J Soc Gynecol Investig. 2006 Feb;13(2):136-44 [16443508.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2257-61 [16461460.001]
  • [Cites] Obstet Gynecol Clin North Am. 2006 Mar;33(1):13-39 [16504804.001]
  • [Cites] Nat Cell Biol. 2006 Mar;8(3):278-84 [16489342.001]
  • [Cites] Nucleic Acids Res. 2006;34(6):1765-71 [16582102.001]
  • [Cites] Fertil Steril. 2006 Feb;85(2):462-7 [16595228.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 May 2;103(18):7024-9 [16641092.001]
  • [Cites] Mol Hum Reprod. 2006 Apr;12(4):245-56 [16571622.001]
  • [Cites] Hum Reprod. 2006 Jun;21(6):1380-6 [16488906.001]
  • [Cites] Gastroenterology. 2006 Jun;130(7):2113-29 [16762633.001]
  • [Cites] Cancer Res. 2006 Jun 15;66(12):6097-104 [16778182.001]
  • [Cites] Hum Reprod Update. 2006 Jul-Aug;12(4):385-400 [16603566.001]
  • [Cites] Hum Reprod. 2006 Sep;21(9):2408-16 [16720624.001]
  • [Cites] J Biol Chem. 2007 Mar 16;282(11):8256-64 [17220301.001]
  • [Cites] Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3432-7 [17360662.001]
  • [Cites] Genes Dev. 2007 Mar 15;21(6):682-93 [17369401.001]
  • [Cites] Cell. 2007 Apr 6;129(1):147-61 [17382377.001]
  • [Cites] Fertil Steril. 2007 Apr;87(4):725-36 [17430732.001]
  • [Cites] Cancer Res. 2007 Nov 15;67(22):11001-11 [18006846.001]
  • [Cites] Dev Dyn. 2007 Dec;236(12):3321-31 [17685479.001]
  • [Cites] Nat Rev Mol Cell Biol. 2007 Dec;8(12):970-82 [18000526.001]
  • [Cites] Mol Cancer. 2007;6:60 [17894887.001]
  • [Cites] Oncogene. 2007 Nov 29;26(54):7590-5 [17563749.001]
  • [Cites] Cancer Res. 2007 Dec 1;67(23):11099-101 [18056431.001]
  • [Cites] Stem Cell Rev. 2007 Dec;3(4):249-55 [17955391.001]
  • [Cites] Reprod Sci. 2007 Dec;14(8 Suppl):20-7 [18089606.001]
  • [Cites] Proc Natl Acad Sci U S A. 2007 Dec 18;104(51):20350-5 [18077375.001]
  • [Cites] Trends Pharmacol Sci. 2008 Jan;29(1):12-5 [18068232.001]
  • [Cites] Oncogene. 2008 Jan 10;27(3):378-86 [17621267.001]
  • [Cites] Nat Rev Immunol. 2008 Feb;8(2):120-30 [18204468.001]
  • [Cites] Curr Stem Cell Res Ther. 2007 Dec;2(4):264-71 [18220910.001]
  • (PMID = 18951332.001).
  • [ISSN] 1526-4564
  • [Journal-full-title] Seminars in reproductive medicine
  • [ISO-abbreviation] Semin. Reprod. Med.
  • [Language] ENG
  • [Grant] United States / NICHD NIH HHS / HD / HD037432-08; United States / NICHD NIH HHS / HD / R01 HD037432; United States / NICHD NIH HHS / HD / HD37432; United States / NICHD NIH HHS / HD / R01 HD037432-08
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Gonadal Steroid Hormones; 0 / MicroRNAs
  • [Number-of-references] 117
  • [Other-IDs] NLM/ NIHMS121237; NLM/ PMC2710997
  •  go-up   go-down


59. Clauss S, Höller S, Hegi L, Blum R, Hösli I: ["STUMP" (smooth muscle tumour of uncertain malignant potential), a tumour of the uterus in pregnancy--a diagnostic and therapeutic challenge]. Z Geburtshilfe Neonatol; 2010 Apr;214(2):74-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] ["STUMP" (smooth muscle tumour of uncertain malignant potential), a tumour of the uterus in pregnancy--a diagnostic and therapeutic challenge].
  • [Transliterated title] "STUMP" (smooth muscle tumor of uncertain malignant potential), ein Uterustumor in der Schwangerschaft, eine diagnostische und therapeutische Herausforderung.
  • We present the case of a preterm birth in the 27 (th) week of gestation, probably due to a chorionamnionitis, with the coincidental finding of a STUMP (smooth muscle tumour of uncertain malignant potential).
  • The STUMP is a rare tumour entity characterised by smooth muscle cells which is difficult to classify by means of histology.
  • The WHO classification of mesenchymal tumours allocates STUMP as an intermediate tumour between a benign leiomyoma and a malignant leiomyosarcoma.
  • If histological criteria of malignancy are not fulfilled because the type of necrosis is in doubt or the interpretation of mitotic figures is ambiguous and the tumour cannot reliably be classified as a leiomyoma, it is classified as a STUMP.
  • Compared to malignant leiomyosarcoma, STUMP has a superior prognosis, but the biological potential of the tumour remains unclear; lymphogenic and haematogenic dissemination seems possible even after a long period of time.
  • STUMP represents a challenge in diagnosis and treatment recommendations.
  • We present the first description of a case of STUMP during pregnancy, raising the question of whether the histological finding in tumours of the uterus during pregnancy are important.
  • [MeSH-major] Smooth Muscle Tumor / diagnosis. Smooth Muscle Tumor / therapy. Uterine Neoplasms / diagnosis. Uterine Neoplasms / therapy

  • Genetic Alliance. consumer health - Pregnancy.
  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20411475.001).
  • [ISSN] 1439-1651
  • [Journal-full-title] Zeitschrift für Geburtshilfe und Neonatologie
  • [ISO-abbreviation] Z Geburtshilfe Neonatol
  • [Language] ger
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


60. Suresh L, Matsumura E, Calixto LE, Ruckert E, Aguirre A: Intraosseous angiomyoma of the mandible. Gen Dent; 2007 Mar-Apr;55(2):132-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Leiomyoma is a benign smooth muscle tumor that usually is found in the uterus, gastrointestinal tract, or skin.
  • Microscopically, 53% of gnathic leiomyomas have a prominent vascular component that warrants a diagnosis of angiomyoma.
  • [MeSH-major] Angiomyoma / pathology. Mandibular Neoplasms / pathology
  • [MeSH-minor] Diagnosis, Differential. Female. Humans. Middle Aged

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17333986.001).
  • [ISSN] 0363-6771
  • [Journal-full-title] General dentistry
  • [ISO-abbreviation] Gen Dent
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


61. Tomsová M, Pohnĕtalová D, Spacek J: [Rare tumours of myometrium--intravenous leiomyomatosis and benign metastatic leiomyoma]. Ceska Gynekol; 2007 Apr;72(2):136-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Rare tumours of myometrium--intravenous leiomyomatosis and benign metastatic leiomyoma].
  • Leiomyomas are the most common benign uterine neoplasms of the myometrium.
  • We present a case of intravenous leiomyomatosis in a 52-year-old woman and a case of benign metastasizing leiomyoma in a 45-year-old woman.
  • Intravenous leiomyomatosis is an uncommon condition in which morphologically benign smooth muscle is present within the lumina of the veins.
  • Benign metastasizing leiomyoma is a very rare phenomenon where histologically benign smooth muscle tumours are present at distant sites, particularly in the lungs, in women having histologically benign uterine leiomyoma.


62. Deen S, Duncan TJ, Hammond RH: Malignant female adnexal tumors of probable Wolffian origin. Int J Gynecol Pathol; 2007 Oct;26(4):383-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Malignant female adnexal tumors of probable Wolffian origin.
  • Female adnexal tumors of probable Wolffian origin are rare.
  • Although the histological features of the benign tumors are recognized, features of malignancy are not well defined in published work because these tumors are particularly rare.
  • A pelvic transvaginal ultrasound scan demonstrated a midline, highly vascular, predominantly solid pelvic mass, approximately 14 cm, posterior to the uterus.
  • Immunohistochemical staining and electron microscopy supported the diagnosis of female adnexal tumor of probable Wolffian origin.
  • There was significant and widespread nuclear pleomorphism with increased mitotic activity endorsing the diagnosis of a malignant tumor.
  • [MeSH-minor] Aged, 80 and over. Female. Humans. Hysterectomy. Neoplasm Recurrence, Local / pathology. Uterine Hemorrhage / etiology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17885487.001).
  • [ISSN] 0277-1691
  • [Journal-full-title] International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists
  • [ISO-abbreviation] Int. J. Gynecol. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


63. Erdem S, Iskender C, Avsar AF, Altundag OB, Ustunyurt E: Benign cystic lymphangioma presenting as a pelvic mass. J Obstet Gynaecol Res; 2006 Dec;32(6):628-30
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Benign cystic lymphangioma presenting as a pelvic mass.
  • We report a case of a 48-year-old woman with a complaint of chronic pelvic pain with a pelvic mass not related with uterus or adnexes.
  • Preoperative ultrasonography or contrast enhanced computed tomography did not give accurate information on the origin of tumor.
  • [MeSH-major] Lymphangioma, Cystic / complications. Pelvic Neoplasms / complications. Pelvic Pain / etiology. Retroperitoneal Neoplasms / complications

  • Genetic Alliance. consumer health - Lymphangioma.
  • MedlinePlus Health Information. consumer health - Pelvic Pain.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17100830.001).
  • [ISSN] 1341-8076
  • [Journal-full-title] The journal of obstetrics and gynaecology research
  • [ISO-abbreviation] J. Obstet. Gynaecol. Res.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


64. Kitajima K, Murakami K, Kaji Y, Sugimura K: Spectrum of FDG PET/CT findings of uterine tumors. AJR Am J Roentgenol; 2010 Sep;195(3):737-43
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Spectrum of FDG PET/CT findings of uterine tumors.
  • OBJECTIVE: The purpose of this article is to review FDG PET/CT and MRI findings in a variety of benign and malignant tumors of the uterus and to become familiar with the wide variety of FDG PET/CT findings of this entity.
  • CONCLUSION: Benign uterine tumors generally have mild FDG uptake, and leiomyoma rarely shows high uptake.
  • Uterine malignant tumors generally have intense FDG uptake, whereas malignant uterine tumors that are small or that have low cellular density often show minimal uptake.
  • [MeSH-major] Positron-Emission Tomography / methods. Tomography, X-Ray Computed / methods. Uterine Neoplasms / radiography. Uterine Neoplasms / radionuclide imaging
  • [MeSH-minor] Endometrial Neoplasms / radiography. Endometrial Neoplasms / radionuclide imaging. Female. Fluorodeoxyglucose F18. Humans. Leiomyoma / radiography. Leiomyoma / radionuclide imaging. Magnetic Resonance Imaging. Precancerous Conditions / radiography. Precancerous Conditions / radionuclide imaging. Radiopharmaceuticals. Sarcoma / radiography. Sarcoma / radionuclide imaging

  • MedlinePlus Health Information. consumer health - CT Scans.
  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20729454.001).
  • [ISSN] 1546-3141
  • [Journal-full-title] AJR. American journal of roentgenology
  • [ISO-abbreviation] AJR Am J Roentgenol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Radiopharmaceuticals; 0Z5B2CJX4D / Fluorodeoxyglucose F18
  • [Number-of-references] 14
  •  go-up   go-down


65. Shi Y, Liu Z, Peng Z, Liu H, Yang K, Yao X: The diagnosis and treatment of Mullerian adenosarcoma of the uterus. Aust N Z J Obstet Gynaecol; 2008 Dec;48(6):596-600
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The diagnosis and treatment of Mullerian adenosarcoma of the uterus.
  • BACKGROUND: Adenosarcoma of the uterus is one of the rare types of gynaecological malignant tumours.
  • Poor awareness of it among clinicians makes it difficult to diagnose correctly and timely, so it is helpful to enrich and update our knowledge about the tumour with new information of patients.
  • AIM: To improve the level of diagnosis and treatment of Mullerian adenosarcoma of the uterus.
  • METHODS: The medical data of nine patients with Mullerian adenosarcoma of the uterus who were treated from May 1995 to March 2006 in our hospital were analysed retrospectively.
  • RESULTS: Patients typically presented with abnormal uterine bleeding, pain in the lower abdomen, enlargement of the uterus, a mass in the uterine cavity and/or a cervical neoplasm.
  • Microscopically, the glands were lined by benign or atypical glandular epithelium, together with sarcomatous stromal cells which showed characteristic structures of 'periglandular cuff' of increased cellularity and 'intraglandular polypoid projections'.
  • The primary diagnostic rate was 33.3% and the average interval from symptom onset to final diagnosis was 13 months and eight weeks for pre- and postmenopausal patients, respectively.
  • CONCLUSIONS: The most common symptom of adenosarcoma of the uterus is abnormal uterine bleeding.
  • [MeSH-major] Adenosarcoma / diagnosis. Mixed Tumor, Mullerian / diagnosis. Neoplasms, Germ Cell and Embryonal / diagnosis. Uterine Cervical Neoplasms / diagnosis. Uterine Neoplasms / diagnosis
  • [MeSH-minor] Adult. Age Factors. Diagnosis, Differential. Female. Humans. Middle Aged. Neoplasm Staging. Prognosis. Retrospective Studies. Treatment Outcome. Young Adult


66. O'Neill CJ, McCluggage WG: p16 expression in the female genital tract and its value in diagnosis. Adv Anat Pathol; 2006 Jan;13(1):8-15
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] p16 expression in the female genital tract and its value in diagnosis.
  • p16 is a cyclin-dependent kinase-4 inhibitor that is expressed in a limited range of normal tissues and tumors.
  • In cervical squamous lesions, p16 is positive in most high-grade cervical intraepithelial neoplasia (CIN) and in some cases of low-grade CIN, usually those associated with high-risk HPV. p16 may be useful to identify small focal high-grade CIN lesions, to distinguish some cases of CIN involving immature metaplastic squamous epithelium from immature metaplastic squamous epithelium not involved by CIN and to distinguish high-grade CIN from benign mimics.
  • In cervical glandular lesions, p16 is useful, as part of a panel, in the distinction between adenocarcinoma in situ (diffusely positive) and benign mimics, including tuboendometrial metaplasia and endometriosis, which are usually p16-negative or focally positive. p16 may be used, in combination with other markers, to distinguish between a cervical adenocarcinoma (diffuse positivity) and an endometrioid-type endometrial adenocarcinoma (negative or focally positive).
  • Some uterine serous carcinomas are diffusely positive.
  • In the vulva, p16 is positive in HPV-associated vulval intraepithelial neoplasia (VIN) but negative in VIN not associated with HPV.
  • Similarly, HPV-associated invasive squamous carcinomas are p16-positive, whereas the more common non-HPV-associated neoplasms are largely negative or focally positive.
  • In the uterus, p16 positivity is more common and widespread in leiomyosarcomas than leiomyomas, and this may be a useful aid to diagnosis, although problematic uterine smooth muscle neoplasms have not been extensively studied.
  • Some ovarian serous carcinomas, similar to their uterine counterparts, are p16-positive.
  • [MeSH-major] Cyclin-Dependent Kinase Inhibitor p16 / analysis. Genital Neoplasms, Female / diagnosis
  • [MeSH-minor] Adenocarcinoma / chemistry. Adenocarcinoma / diagnosis. Adenocarcinoma / genetics. Biomarkers, Tumor / analysis. Biomarkers, Tumor / genetics. Carcinoma, Small Cell / chemistry. Carcinoma, Small Cell / diagnosis. Carcinoma, Small Cell / genetics. Cystadenocarcinoma, Serous / chemistry. Cystadenocarcinoma, Serous / diagnosis. Cystadenocarcinoma, Serous / genetics. Diagnosis, Differential. Endometrial Neoplasms / chemistry. Endometrial Neoplasms / diagnosis. Endometrial Neoplasms / genetics. Female. Genes, p16. Genitalia, Female / chemistry. Genitalia, Female / physiopathology. Humans. Immunohistochemistry. Ovarian Neoplasms / chemistry. Ovarian Neoplasms / diagnosis. Ovarian Neoplasms / genetics. Tumor Suppressor Proteins / analysis. Tumor Suppressor Proteins / genetics. Uterine Cervical Neoplasms / chemistry. Uterine Cervical Neoplasms / diagnosis. Uterine Cervical Neoplasms / genetics. Uterine Neoplasms / chemistry. Uterine Neoplasms / diagnosis. Uterine Neoplasms / genetics. Vulvar Neoplasms / chemistry. Vulvar Neoplasms / classification. Vulvar Neoplasms / diagnosis. Vulvar Neoplasms / genetics

  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16462152.001).
  • [ISSN] 1072-4109
  • [Journal-full-title] Advances in anatomic pathology
  • [ISO-abbreviation] Adv Anat Pathol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Cyclin-Dependent Kinase Inhibitor p16; 0 / Tumor Suppressor Proteins
  • [Number-of-references] 65
  •  go-up   go-down


67. Cobellis L, Pecori E, Rigatti F, Scaffa C, Rotondi M, Messalli EM: A rare case of female pelvic mass: angioleiomyoma of the broad ligament. Eur J Gynaecol Oncol; 2007;28(5):418-20
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Angioleiomyoma is a benign mesenchymal neoplasm composed of smooth muscle cells and thick-walled vessels.
  • Angioleiomyoma is a very rare tumor among the ever-expanding repertoire of growth variants described in benign uterine leiomyoma.
  • More rare is a solitary tumor of the broad ligament.
  • Thus angioleiomyoma of the broad ligament is an extremely rare benign tumor of the female pelvis.
  • The site of the benign mass was the left broad ligament of the uterus.
  • On pathologic examination of the specimen, the tumor was diagnosed as angioleiomyoma.
  • We present a case of angioleiomyoma of the broad ligament because of its extreme rarity and the large size of the tumor.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17966227.001).
  • [ISSN] 0392-2936
  • [Journal-full-title] European journal of gynaecological oncology
  • [ISO-abbreviation] Eur. J. Gynaecol. Oncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


68. Teppone M, Avakyan R: Extremely high-frequency therapy in oncology. J Altern Complement Med; 2010 Nov;16(11):1211-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHOD: At the early stage of these studies, efficacy and safety of millimeter electromagnetic radiation (extremely high frequency [EHF]) was proved for various types of malignant tumors.
  • The majority of the further studies demonstrated the high efficacy and safety of millimeter wave radiation in treating patients suffering from both benign and malignant tumors.
  • RESULTS: Developments led to treatment on skin melanoma, cancer of the ear-nose-throat, bowel and breast cancer, cancer of the uterus, lung, and stomach, solid tumors, as well as lymphoma.
  • (3) prevention of metastases, relapses, and dissemination of the tumor;.
  • [MeSH-major] Neoplasms / radiotherapy

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20973733.001).
  • [ISSN] 1557-7708
  • [Journal-full-title] Journal of alternative and complementary medicine (New York, N.Y.)
  • [ISO-abbreviation] J Altern Complement Med
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  •  go-up   go-down


69. Dickson BC, Srigley JR, Pollett AF, Blackstein ME, Honey JD, Juco JW: Rectal gastrointestinal stromal tumor mimicking a primary prostatic lesion. Can J Urol; 2008 Jun;15(3):4112-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Rectal gastrointestinal stromal tumor mimicking a primary prostatic lesion.
  • The interstitial cells of Cajal have been identified in locations beyond the gastrointestinal tract, including the prostate, uterus and bladder.
  • Indeed, there are reports of primary gastrointestinal stromal tumor (GIST) arising from each of these sites.
  • We report the case of a 72-year old male who presented with benign prostatic hypertrophy and was diagnosed on retropubic prostatectomy as having a GIST.
  • The purpose of our report is to highlight the need to assiduously rule-out gastrointestinal sources of GIST prior to making the diagnosis of primary prostatic GIST.
  • [MeSH-major] Gastrointestinal Stromal Tumors / diagnosis. Prostatic Neoplasms / diagnosis. Rectal Neoplasms / diagnosis
  • [MeSH-minor] Aged. Diagnosis, Differential. Humans. Magnetic Resonance Imaging. Male

  • MedlinePlus Health Information. consumer health - Prostate Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18570720.001).
  • [ISSN] 1195-9479
  • [Journal-full-title] The Canadian journal of urology
  • [ISO-abbreviation] Can J Urol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Canada
  •  go-up   go-down


70. Maimoon S, Wilkinson A, Mahore S, Bothale K, Patrikar A: Cotyledonoid leiomyoma of the uterus. Indian J Pathol Microbiol; 2006 Apr;49(2):289-91
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cotyledonoid leiomyoma of the uterus.
  • In the growing knowledge of rare interesting tumors, the cotyledonoid leiomyoma is a tumor with an alarming appearance, of benign nature, but dealt with undue severity.
  • We report a case of cotyledonoid leiomyoma in a 40 yr old female who presented with urinary retention and in whom a clinical diagnosis of uterine fibroid was made.
  • On laparotomy, friable nodules were seen in the lower part of the uterus.
  • Hence the diagnosis of sarcoma was considered and total abdominal hysterectomy with unilateral salpingo-oopherectomy was done.
  • Increased awareness of this grossly alarming variant of benign leiomyoma can help avoid over treatment.
  • [MeSH-major] Leiomyoma / pathology. Uterine Neoplasms / pathology
  • [MeSH-minor] Adult. Diagnosis, Differential. Female. Humans. Leiomyosarcoma / diagnosis

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • MedlinePlus Health Information. consumer health - Uterine Fibroids.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16933745.001).
  • [ISSN] 0377-4929
  • [Journal-full-title] Indian journal of pathology & microbiology
  • [ISO-abbreviation] Indian J Pathol Microbiol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] India
  •  go-up   go-down


71. Scheurig C, Islam T, Zimmermann E, Hamm B, Kroencke TJ: Uterine artery embolization in patients with symptomatic diffuse leiomyomatosis of the uterus. J Vasc Interv Radiol; 2008 Feb;19(2 Pt 1):279-84
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Uterine artery embolization in patients with symptomatic diffuse leiomyomatosis of the uterus.
  • Six patients with symptomatic diffuse uterine leiomyomatosis underwent technically successful uterine artery embolization.
  • After a median follow-up of 16 months, five women presented with permanent alleviation of symptoms and a normalized quality of life according to the Uterine Fibroid Symptom and Quality of Life questionnaire.
  • Failure of therapy occurred in one patient with atypical growth of fibroid tumor tissue shortly after embolization, which was suspicious for malignancy.
  • Hysterectomy was performed and pathologic evaluation revealed benign leiomyomatosis.
  • [MeSH-major] Embolization, Therapeutic / methods. Leiomyomatosis / therapy. Uterine Neoplasms / therapy. Uterus / blood supply

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18341962.001).
  • [ISSN] 1051-0443
  • [Journal-full-title] Journal of vascular and interventional radiology : JVIR
  • [ISO-abbreviation] J Vasc Interv Radiol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


72. Maresca A, Gagliano C, Marcuzzi A: Leiomyoma of the hand: a case report. Chir Main; 2005 Jun-Aug;24(3-4):193-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • This is a benign tumor originating from non-striated muscle that is very uncommon in the hand.
  • The uterus is considered the most common location for leiomyoma and when it occurs in the extremities, it is more common in the leg, ankle and foot.
  • It usually occurs in the third and fourth decades of life and it is rarely diagnosed before surgery as the diagnosis can only be confirmed histologically.
  • [MeSH-major] Leiomyoma / diagnosis. Muscle Neoplasms / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16121629.001).
  • [ISSN] 1297-3203
  • [Journal-full-title] Chirurgie de la main
  • [ISO-abbreviation] Chir Main
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] France
  •  go-up   go-down


73. Tahlan A, Nanda A, Mohan H: Uterine adenomyoma: a clinicopathologic review of 26 cases and a review of the literature. Int J Gynecol Pathol; 2006 Oct;25(4):361-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Uterine adenomyoma: a clinicopathologic review of 26 cases and a review of the literature.
  • The aim of this study is to highlight the importance of diagnosing uterine adenomyoma and help in differentiating it from other sinister lesions.
  • Adenomyoma of the uterus is a circumscribed nodular aggregate of benign endometrial glands surrounded by endometrial stroma with leiomyomatous smooth muscle bordering the endometrial stromal component.
  • A retrospective analysis of 26 consecutive cases of uterine adenomyomas diagnosed in the Department of Pathology, Government Medical College, Chandigarh from January 1994 to December 2004 was done, and their clinical and histological features were analyzed.
  • The criterion used for case identification was a circumscribed mass composed of benign endometrial glands with a stromal component consisting of endometrial type stroma surrounded by leiomyomatous smooth muscle.
  • Thirteen patients underwent panhysterectomy; 7, total hysterectomy; 1, subtotal hysterectomy; 4, polypectomy or tumor removal; and 1, curettage.
  • Five tumors showed cystic spaces filled with dark brown material.
  • On microscopic examination, the tumors were well demarcated from the surrounding structures.
  • The glands were lined by benign proliferative pseudostratified columnar epithelium.
  • This study highlights the importance of correctly identifying this fairly common entity and helps to distinguish adenomyoma from other similar appearing benign and malignant lesions.
  • [MeSH-major] Adenomyoma. Uterine Neoplasms
  • [MeSH-minor] Adult. Female. Humans. Leiomyoma / pathology. Middle Aged. Uterine Cervical Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16990713.001).
  • [ISSN] 0277-1691
  • [Journal-full-title] International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists
  • [ISO-abbreviation] Int. J. Gynecol. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 15
  •  go-up   go-down


74. Kajo K, Zúbor P, Krivus S, Danko J: [Angiolipoleiomyoma of the uterus. Case report and literature review]. Ceska Gynekol; 2010 Feb;75(1):54-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Angiolipoleiomyoma of the uterus. Case report and literature review].
  • OBJECTIVE: The rare case presentation of angiolipoleiomyoma (ALLM) of the uterus with review of diagnostic and discriminative information for this entity.
  • CONCLUSION: The ALLM of the uterus is rare benign mixed mesenchyme tumor consisting of smooth muscle bundles, foci of mature fat tissue and abnormal vessels.
  • The presented case is describing a 53-year-old women hysterectomized for multiple uterine myoma of which two showed the histological signs of ALLM.
  • On imunohistochemical profile are these tumors negative for melanocytic features, e.g.
  • HMB-45, what distinguishes them from angiomyolipomas, which are currently categorized into so called PEComas - tumors originating from perivascular epithelial cells.

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20437838.001).
  • [ISSN] 1210-7832
  • [Journal-full-title] Ceska gynekologie
  • [ISO-abbreviation] Ceska Gynekol
  • [Language] SLO
  • [Publication-type] Case Reports; English Abstract; Journal Article; Review
  • [Publication-country] Czech Republic
  • [Number-of-references] 18
  •  go-up   go-down


75. Lee HJ, Choi J, Kim KR: Pulmonary benign metastasizing leiomyoma associated with intravenous leiomyomatosis of the uterus: clinical behavior and genomic changes supporting a transportation theory. Int J Gynecol Pathol; 2008 Jul;27(3):340-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pulmonary benign metastasizing leiomyoma associated with intravenous leiomyomatosis of the uterus: clinical behavior and genomic changes supporting a transportation theory.
  • Benign metastasizing leiomyoma is a rare lesion characterized by benign-appearing smooth muscle tumor most frequently involving the lung and usually associated with a benign leiomyoma or intravenous leiomyomatosis of the uterus.
  • The pathogenetic mechanism of the tumor has not been clarified, but the possibilities including hormone-sensitive in situ proliferations of smooth muscle bundles, mechanical displacement or intravascular spread of preexisting benign uterine tumor tissue, and metastasized very low-grade uterine leiomyosarcoma have been proposed.
  • We described a case of pulmonary benign metastasizing leiomyoma associated with a uterine intravenous leiomyomatosis in a 46-year-old woman with a result of comparative genomic hybridization study.
  • Unresected pulmonary nodules were left untreated for 13 months after the hysterectomy and wedge biopsy of 3 pulmonary nodules to show no further growth, suggesting clinical behavior of nonmalignant tumor in our case.
  • Benign metastasizing leiomyomas may comprise a heterogeneous group of tumors in terms of their malignant potential and pathogenetic mechanism.
  • [MeSH-major] Leiomyoma / pathology. Leiomyomatosis / pathology. Lung Neoplasms / secondary. Uterine Neoplasms / pathology
  • [MeSH-minor] DNA, Neoplasm. Female. Genomics. Humans. Middle Aged. Nucleic Acid Hybridization

  • Genetic Alliance. consumer health - Intravenous leiomyomatosis.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • MedlinePlus Health Information. consumer health - Uterine Fibroids.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18580311.001).
  • [ISSN] 1538-7151
  • [Journal-full-title] International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists
  • [ISO-abbreviation] Int. J. Gynecol. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / DNA, Neoplasm
  •  go-up   go-down


76. Rabban JT, Zaloudek CJ, Shekitka KM, Tavassoli FA: Inflammatory myofibroblastic tumor of the uterus: a clinicopathologic study of 6 cases emphasizing distinction from aggressive mesenchymal tumors. Am J Surg Pathol; 2005 Oct;29(10):1348-55
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Inflammatory myofibroblastic tumor of the uterus: a clinicopathologic study of 6 cases emphasizing distinction from aggressive mesenchymal tumors.
  • Inflammatory myofibroblastic tumor (IMT) is an indolent spindle cell proliferation that can histologically resemble various malignant mesenchymal neoplasms; however, it generally behaves as a benign or locally recurrent tumor.
  • We report the clinical and pathologic features of six IMTs of the uterus, one of which was included in a previous report, and emphasize the histologic and immunohistochemical features that distinguish IMTs from uterine spindle cell neoplasms that require aggressive treatment.
  • We compared ALK expression in uterine IMTs with that in uterine mesenchymal neoplasms with which it may be confused.
  • Three grew as polypoid masses that arose in the lower uterine segment, and two of these prolapsed through the cervical os.
  • The three other tumors grew as bulky myometrial masses with focally irregular borders and infiltrated the endometrium, parametrium, or cervical stroma.
  • A lymphoplasmacytic infiltrate was present in all of the tumors, and most had a myxoid background.
  • Mitotic activity ranged from 0 to 2 mitotic figures per 10 high power fields (HPF) except in one tumor that focally had up to 8 mitotic figures per 10 HPF.
  • No ALK expression was identified in uterine leiomyoma (n = 7), leiomyosarcoma (n = 6), carcinosarcoma (n = 4), endometrial stromal sarcoma (n = 4), or normal uterine tissues.
  • Follow-up ranging from 1.5 years to 5 years in 4 patients with uterine IMTs revealed no recurrence or metastasis.
  • IMTs should be differentiated from aggressive uterine mesenchymal tumors because they can be treated conservatively and have a more favorable prognosis.
  • [MeSH-major] Myofibroma / pathology. Uterine Neoplasms / pathology
  • [MeSH-minor] Adolescent. Adult. Child. Diagnosis, Differential. Female. Humans. Immunohistochemistry. Middle Aged. Protein-Tyrosine Kinases / metabolism. Receptor Protein-Tyrosine Kinases. Sarcoma / metabolism. Sarcoma / pathology

  • Genetic Alliance. consumer health - Inflammatory myofibroblastic tumor.
  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16160478.001).
  • [ISSN] 0147-5185
  • [Journal-full-title] The American journal of surgical pathology
  • [ISO-abbreviation] Am. J. Surg. Pathol.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] EC 2.7.10.1 / Protein-Tyrosine Kinases; EC 2.7.10.1 / Receptor Protein-Tyrosine Kinases; EC 2.7.10.1 / anaplastic lymphoma kinase
  •  go-up   go-down


77. Sieunarine K, Cowie AS, Bartlett JD, Lindsay I, Smith JR: A novel approach in the management of a recurrent adenomatoid tumor of the uterus utilizing a Strassman technique. Int J Gynecol Cancer; 2005 Jul-Aug;15(4):671-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A novel approach in the management of a recurrent adenomatoid tumor of the uterus utilizing a Strassman technique.
  • Adenomatoid tumors of the uterus are uncommon benign lesions derived from mesothelium, with a prevalence of 1.2% in one study of 1 000 unselected hysterectomy specimens.
  • They are usually small and near the serosal surface; however, they may be large and diffuse (giant adenomatoid tumors).
  • This transpired to be an adenomatoid tumor, and she underwent three transcervical resections of the tumor (TCRT) over a period of 12 months for tumor recurrence and failure of symptom resolution.
  • The last TCRT was performed with ultrasound guidance and laparoscopic visualization of the uterus to the resection point of blanching of the serosal surface.
  • A specialist opinion on the suitability of vascular embolization of the tumor judged that it would be ineffective for this lesion.
  • She then underwent a Strassman procedure and removal of the adenomatoid tumor.
  • This involved dissection of ureters and pelvic vasculature, selective temporary ligation of uterine arteries, hemisection of the uterus, and excision of the tumor with frozen sections to ensure clear tumor margins and resuturing of the uterine halves.
  • Temporary vascular occlusion of the uterine arteries and ovarian vessels allowed a Strassman procedure, which resulted in successful resection of a recurrent giant adenomatoid tumor of the uterus, with fertility preservation in a young nulliparous woman.
  • Two and a half years on there is no evidence of tumor recurrence.
  • [MeSH-major] Adenomatoid Tumor / surgery. Gynecologic Surgical Procedures / methods. Neoplasm Recurrence, Local / surgery. Uterine Neoplasms / surgery. Uterus / blood supply

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16014122.001).
  • [ISSN] 1048-891X
  • [Journal-full-title] International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
  • [ISO-abbreviation] Int. J. Gynecol. Cancer
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


78. Biermann K, Heukamp LC, Büttner R, Zhou H: Uterine tumor resembling an ovarian sex cord tumor associated with metastasis. Int J Gynecol Pathol; 2008 Jan;27(1):58-60
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Uterine tumor resembling an ovarian sex cord tumor associated with metastasis.
  • Uterine tumors resembling ovarian sex-cord tumors (UTROSCT) are very rare, usually benign uterine tumors, and are probably derived from uterine mesenchymal stem cells.
  • Four years after a diagnosis of UTROSCT of the uterine corpus, the patient developed obstructive ileus due to a large infiltrating tumor within the small bowel with the same morphology and expression pattern as the previously diagnosed UTROSCT.
  • In addition, 2 benign gastrointestinal stromal tumors were detected in the same patient.
  • This case indicates that although the majority of UTROSCT are benign tumors, some of them might undergo malignant transformation and have a metastatic potency.
  • [MeSH-major] Intestinal Neoplasms / secondary. Ovarian Neoplasms / pathology. Sex Cord-Gonadal Stromal Tumors / pathology. Uterine Neoplasms / pathology
  • [MeSH-minor] Aged. Biomarkers, Tumor / analysis. Female. Gastrointestinal Stromal Tumors / metabolism. Gastrointestinal Stromal Tumors / pathology. Humans. Immunohistochemistry. Intestinal Obstruction / etiology. Intestine, Small / metabolism. Intestine, Small / pathology. Neoplasms, Second Primary / metabolism. Neoplasms, Second Primary / pathology

  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18156976.001).
  • [ISSN] 0277-1691
  • [Journal-full-title] International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists
  • [ISO-abbreviation] Int. J. Gynecol. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


79. Mangioni S, Viganò P, Lattuada D, Abbiati A, Vignali M, Di Blasio AM: Overexpression of the Wnt5b gene in leiomyoma cells: implications for a role of the Wnt signaling pathway in the uterine benign tumor. J Clin Endocrinol Metab; 2005 Sep;90(9):5349-55
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Overexpression of the Wnt5b gene in leiomyoma cells: implications for a role of the Wnt signaling pathway in the uterine benign tumor.
  • CONTEXT: Uterine leiomyomas are the most common tumors in the human female pelvis and the leading indication for pelvic surgery.
  • Treatment with 9-cis retinoic acid significantly inhibited Wnt5b expression in myometrial SMC but not in their leiomyoma counterparts.
  • [MeSH-major] Leiomyoma / metabolism. Proto-Oncogene Proteins / metabolism. Signal Transduction. Uterine Neoplasms / metabolism

  • Genetic Alliance. consumer health - Uterine Fibroid.
  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • MedlinePlus Health Information. consumer health - Uterine Fibroids.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15972578.001).
  • [ISSN] 0021-972X
  • [Journal-full-title] The Journal of clinical endocrinology and metabolism
  • [ISO-abbreviation] J. Clin. Endocrinol. Metab.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Cell Cycle Proteins; 0 / Intercellular Signaling Peptides and Proteins; 0 / Membrane Proteins; 0 / Proto-Oncogene Proteins; 0 / RNA, Messenger; 0 / SFRP1 protein, human; 0 / WNT5B protein, human; 0 / Wnt Proteins
  •  go-up   go-down


80. Haberal A, Cil AP, Gunes M, Cavusoglu D: Papillary adenofibroma of the cervix: a case report. Ultrasound Obstet Gynecol; 2005 Aug;26(2):186-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Adenofibroma is an extremely rare benign biphasic neoplasm that is classified into the mixed epithelial and mesenchymal tumor group.
  • Preoperative diagnosis of this tumor is usually difficult.
  • This lesion appears to be clinically and histologically benign but must be differentiated from malignant lesions of the uterus, particularly from adenosarcoma, which can be suggestive of adenofibroma.
  • Accurate diagnosis of these benign tumors permits appropriate counseling of patients.
  • [MeSH-major] Adenofibroma / ultrasonography. Uterine Cervical Neoplasms / ultrasonography


81. Abike F, Temizkan O, Payasli A, Avsar F, Karahan N, Baspinar S: Postmenopausal complete hydatidiform mole: a case report. Maturitas; 2008 Jan 20;59(1):95-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Gestational trophoblastic neoplasia (GTN) is a disease with a course of trophoblastic proliferation, and histologically classified as partial hydatidiform mole, complete mole, invasive and metastatic mole, choriocarcinoma and placental site trophoblastic tumor.
  • Ultrasound examination revealed enlargement of the uterus with endometrial thickness containing hypo/hyper echogeneous and cystic areas.
  • The resected uterus contained an endometrial, cystic, grapelike tumor.
  • CONCLUSION: To our knowledge, our case is the fourth description in the world literature of a benign complete hydatidiform mole in a postmenopausal woman.
  • Although benign gestational trophoblastic disease generally occurs in women of reproductive age and is extremely rare in postmenopausal women, when evaluating patients who are in postmenopausal period the diagnosis of hydatidiform mole must always be considered.

  • Genetic Alliance. consumer health - Hydatidiform mole.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18162339.001).
  • [ISSN] 0378-5122
  • [Journal-full-title] Maturitas
  • [ISO-abbreviation] Maturitas
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Ireland
  • [Chemical-registry-number] 0 / Chorionic Gonadotropin, beta Subunit, Human
  •  go-up   go-down


82. Mesquita FS, Dyer SN, Heinrich DA, Bulun SE, Marsh EE, Nowak RA: Reactive oxygen species mediate mitogenic growth factor signaling pathways in human leiomyoma smooth muscle cells. Biol Reprod; 2010 Feb;82(2):341-51
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Uterine leiomyomas are benign uterine tumors characterized by extracellular matrix remodeling, increased collagen deposition, and increased smooth muscle cell (SMC) proliferation.
  • The necessity of NADPH oxidase-derived ROS for EGF and PDGF signaling pathways leading to cell proliferation points to another potential therapeutic target for treatment and/or prevention of uterine leiomyomas.
  • [MeSH-major] Epidermal Growth Factor / pharmacology. Leiomyoma / metabolism. Platelet-Derived Growth Factor / pharmacology. Reactive Oxygen Species / metabolism. Signal Transduction / physiology. Uterine Neoplasms / metabolism
  • [MeSH-minor] Cell Division / drug effects. Cell Line, Tumor. DNA / biosynthesis. Enzyme Activation / drug effects. Enzyme Inhibitors / pharmacology. Female. Humans. Hydrogen Peroxide / pharmacology. Mitogen-Activated Protein Kinases / metabolism. Muscle, Smooth / metabolism. NADPH Oxidase / antagonists & inhibitors


83. Michy T, Choufi B, Le Bouëdec G, Dauplat J: [Polycythemia and fibromyoma. Case report]. Gynecol Obstet Fertil; 2006 Jul-Aug;34(7-8):622-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Leiomyoma of the uterus is a frequent benign tumor of non menopausal women.
  • The difficulty of diagnosis and the treatment are detailed.
  • [MeSH-major] Leiomyoma / complications. Polycythemia / complications. Uterine Neoplasms / complications

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • MedlinePlus Health Information. consumer health - Uterine Fibroids.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16854610.001).
  • [ISSN] 1297-9589
  • [Journal-full-title] Gynécologie, obstétrique & fertilité
  • [ISO-abbreviation] Gynecol Obstet Fertil
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] France
  • [Chemical-registry-number] 0 / Hemoglobins
  •  go-up   go-down


84. Rizkalla HF, Higgins M, Kelehan P, O'Herlihy C: Pathological findings associated with the presence of a mirena intrauterine system at hysterectomy. Int J Gynecol Pathol; 2008 Jan;27(1):74-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Thirty hysterectomy specimens contained benign leiomyomata with associated reduced reactivity in the uterine cavity and incomplete suppression of the endometrium.
  • In some cases (n = 10), the fibroids had displaced the IUS in the uterine cavity.
  • In addition to leiomyomas, 1 specimen had an atypical polypoid adenomyoma and 1 had a benign adenomatoid tumor.
  • Most women (86%) undergoing hysterectomy because of abnormal uterine bleeding with a Mirena IUS in situ had uterine abnormalities, as revealed by pathological review.
  • Although recent reports have indicated that the IUS can be used successfully in the treatment of menorrhagia due to uterine fibroids, most cases of hysterectomies in this series after failed IUS suppression of menorrhagia contained uterine fibroids.
  • [MeSH-major] Intrauterine Devices, Medicated. Levonorgestrel / therapeutic use. Menorrhagia / drug therapy. Uterus / drug effects. Uterus / pathology
  • [MeSH-minor] Endometrial Hyperplasia / complications. Endometrial Hyperplasia / pathology. Endometriosis / complications. Endometriosis / pathology. Female. Humans. Hysterectomy. Leiomyoma / complications. Leiomyoma / pathology. Retrospective Studies. Treatment Failure. Uterine Neoplasms / complications. Uterine Neoplasms / pathology


85. Yaguchi C, Oi H, Kobayashi H, Miura K, Kanayama N: A case of intravenous leiomyomatosis with high levels of hyaluronan. J Obstet Gynaecol Res; 2010 Apr;36(2):454-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Intravenous leiomyomatosis (IVL) is a rare benign tumor.
  • A 70-year-old woman was referred to our hospital with IVL originating from a uterine leiomyoma and extending to the inferior vena cava.
  • The patient was diagnosed on the basis of the results of various studies, and the tumor was resected completely through a single-stage approach.
  • The intravascular tumor was 20 cm long, multinodular and rubbery.
  • Microscopic findings showed benign smooth muscle that was partly hyalinized and fibrous.
  • Immunohistochemical studies revealed that hyaluronan was expressed more prominently in IVL than in uterine leiomyomas.
  • [MeSH-major] Hyaluronic Acid / analysis. Leiomyomatosis / pathology. Uterus / pathology. Vascular Neoplasms / pathology. Vena Cava, Inferior / pathology

  • Genetic Alliance. consumer health - Intravenous leiomyomatosis.
  • Hazardous Substances Data Bank. HYALURONIC ACID .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20492407.001).
  • [ISSN] 1447-0756
  • [Journal-full-title] The journal of obstetrics and gynaecology research
  • [ISO-abbreviation] J. Obstet. Gynaecol. Res.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Australia
  • [Chemical-registry-number] 9004-61-9 / Hyaluronic Acid
  •  go-up   go-down


86. Shaco-Levy R, Piura B: Uterine adenolipoleiomyoma: a tumor with potential of aggressive behavior. Int J Gynecol Pathol; 2008 Apr;27(2):252-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Uterine adenolipoleiomyoma: a tumor with potential of aggressive behavior.
  • An unusual uterine adenolipoleiomyoma forming intramural and subserosal masses and recurring within 16 months in the form of huge coalescent uterine masses is described.
  • Histology showed the mass to be composed of benign-appearing smooth muscle, mature adipose tissue, and bland endocervical-type glands.
  • The recurrent adenolipoleiomyoma contained, in addition, benign-appearing endometrial-type glands and stroma and showed small foci of atypically proliferating endocervical-type epithelium.
  • This is the fourth report of adenolipoleiomyoma within the uterus, the second with an intramural location, and the first with an aggressive behavior in the form of massive local recurrence.
  • [MeSH-major] Leiomyoma / pathology. Uterine Neoplasms / pathology
  • [MeSH-minor] Female. Humans. Neoplasm Invasiveness. Neoplasm Recurrence, Local / diagnosis. Neoplasm Recurrence, Local / pathology. Uterus / pathology

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • MedlinePlus Health Information. consumer health - Uterine Fibroids.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18317215.001).
  • [ISSN] 1538-7151
  • [Journal-full-title] International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists
  • [ISO-abbreviation] Int. J. Gynecol. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


87. Piura B: Placental site trophoblastic tumor--a challenging rare entity. Eur J Gynaecol Oncol; 2006;27(6):545-51
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Placental site trophoblastic tumor--a challenging rare entity.
  • Placental site trophoblastic tumor (PSTT) is a challenging rare variant of gestational trophoblastic disease (GTD) with variable characteristics.
  • Historically, it was first described in 1895 and was considered a benign lesion until Scully and Young recognized its malignant potential in 1981.
  • More than half of the patients present with disease confined to the uterus, whereas the remainder present with disease extension beyond the uterus.
  • While the outcome of patients with disease confined to the uterus is usually excellent, most patients with disease extension beyond the uterus experience progression of disease and die despite surgery and aggressive chemotherapy.
  • [MeSH-major] Chorionic Gonadotropin, beta Subunit, Human / blood. Trophoblastic Tumor, Placental Site / surgery. Uterine Neoplasms / surgery

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17290581.001).
  • [ISSN] 0392-2936
  • [Journal-full-title] European journal of gynaecological oncology
  • [ISO-abbreviation] Eur. J. Gynaecol. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Italy
  • [Chemical-registry-number] 0 / Biomarkers; 0 / Chorionic Gonadotropin, beta Subunit, Human
  • [Number-of-references] 23
  •  go-up   go-down


88. Egberts JH, Schafmayer C, Bauerschlag DO, Jänig U, Tepel J: Benign abdominal and pulmonary metastasizing leiomyoma of the uterus. Arch Gynecol Obstet; 2006 Aug;274(5):319-22
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Benign abdominal and pulmonary metastasizing leiomyoma of the uterus.
  • BACKGROUND: Benign metastasizing leiomyoma (BML) is a rare disease in which the lung is described to be the most afflicted extrauterine organ.
  • METHODS: We report of a 42-year-old African woman with a BML in the abdomen and lung who had undergone a hysterectomy for uterine leiomyoma 10 years ago.
  • She was admitted to our hospital for investigation of a huge tumor mass in the pelvis consisting of multiple nodules in the abdomen and left lung.
  • Assuming an advanced intraperitoneal malignancy was present, a 'palliative' limited tumor debulking and due to a tumor compressing the sigmoid a Hartmann's procedure was performed.
  • CONCLUSIONS: The review of the literature supports the concept that the primary tumor of BML is located in the uterus and that leiomyomas in the uterus can metastasize leading via hematogenous spread to BML.
  • However, the origin of the tumor remains controversial.
  • [MeSH-major] Abdomen. Leiomyoma / pathology. Lung Neoplasms / secondary. Uterine Neoplasms / pathology
  • [MeSH-minor] Adult. Female. Humans. Hysterectomy. Uterus / pathology. Uterus / surgery

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • MedlinePlus Health Information. consumer health - Uterine Fibroids.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16649038.001).
  • [ISSN] 0932-0067
  • [Journal-full-title] Archives of gynecology and obstetrics
  • [ISO-abbreviation] Arch. Gynecol. Obstet.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


89. Mills AM, Longacre TA: Smooth Muscle Tumors of the Female Genital Tract. Surg Pathol Clin; 2009 Dec;2(4):625-77
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Smooth Muscle Tumors of the Female Genital Tract.
  • Smooth muscle tumors are the most common among mesenchymal tumors in the female genital tract.
  • The vast majority of these neoplasms are clinically benign and easy to diagnose.
  • In contrast, leiomyosarcomas are highly aggressive tumors that may pose considerable diagnostic problems when they display unusual (myxoid or epithelioid) morphology, ambiguous histologic features for malignancy, or an unusual anatomic distribution.
  • Diagnostic criteria for these problematic tumors vary depending on the site and type of histologic differentiation, and are based on a combination of 3 major criteria:.
  • (2) increased mitotic index; and (3) tumor cell necrosis.
  • Certain benign smooth muscle proliferations may show worrisome histologic features or unusual growth patterns, causing concern for leiomyosarcoma.
  • Furthermore, other tumors, including perivascular epithelioid tumors, may mimic leiomyosarcoma.
  • This article discusses conventional smooth muscle tumors as well as unusual subtypes, with emphasis on the diagnostic criteria and problems in differential diagnosis that arise at each site within the female genital tract.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2009 Elsevier Inc. All rights reserved.
  • (PMID = 26838774.001).
  • [ISSN] 1875-9181
  • [Journal-full-title] Surgical pathology clinics
  • [ISO-abbreviation] Surg Pathol Clin
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Keywords] NOTNLM ; Atypical leiomyoma / Benign metastasizing leiomyoma / Disseminated peritoneal leiomyomatosis / Female genital tract / Intravenous leiomyomatosis / Leiomyoma / Leiomyosarcoma / Lymphangioleiomyomatosis / Ovary / PEComa / STUMP / Uterus / Vagina / Vulva
  •  go-up   go-down


90. Giordano G, D'Adda T, Gnetti L, Merisio C, Raboni S: Transitional cell carcinoma of the endometrium associated with benign ovarian brenner tumor: a case report with immunohistochemistry molecular analysis and a review of the literature. Int J Gynecol Pathol; 2007 Jul;26(3):298-304
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Transitional cell carcinoma of the endometrium associated with benign ovarian brenner tumor: a case report with immunohistochemistry molecular analysis and a review of the literature.
  • This neoplasm is very rare, with only 13 cases reported in the international literature.
  • In this paper, a new case of TCCE associated with benign ovarian Brenner tumor is described.
  • Moreover, immunohistochemical and molecular studies are carried out in the effort to establish the phenotype and etiology of this rare neoplasm.
  • The molecular study, by polymerase chain reaction (PCR) failing to reveal the presence of HPV DNA, demonstrates that neither the TCCE nor the ovarian Brenner tumor is caused by an HPV infection.
  • The association of TCCE with benign ovarian Brenner tumor could be a coincidental event.
  • Conversely, this finding could be the manifestation of a multicentric metaplastic process (neometaplasia), involving both the coelomic epithelium of the ovary and the Mullerian epithelium of the uterus, or the evidence of "field effect" that manifests differently at different anatomical sites.
  • In our view, other cases of TCCE associated with ovarian Brenner tumor should be reported to confirm the last 2 hypotheses.
  • [MeSH-major] Brenner Tumor / pathology. Carcinoma, Transitional Cell / pathology. Endometrial Neoplasms / pathology
  • [MeSH-minor] DNA, Neoplasm / chemistry. DNA, Neoplasm / genetics. Female. Humans. Immunohistochemistry. Middle Aged. Polymerase Chain Reaction

  • Genetic Alliance. consumer health - Transitional cell carcinoma.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17581415.001).
  • [ISSN] 0277-1691
  • [Journal-full-title] International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists
  • [ISO-abbreviation] Int. J. Gynecol. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / DNA, Neoplasm
  •  go-up   go-down


91. Onuma K, Dabbs DJ, Bhargava R: Mammaglobin expression in the female genital tract: immunohistochemical analysis in benign and neoplastic endocervix and endometrium. Int J Gynecol Pathol; 2008 Jul;27(3):418-25
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mammaglobin expression in the female genital tract: immunohistochemical analysis in benign and neoplastic endocervix and endometrium.
  • Mammaglobin (MGB), a secretory protein belonging to the uteroglobin/Clara cell protein family, is a sensitive marker for breast carcinoma, but is also reported to be expressed in the female genital tract and its neoplasms.
  • Endocervical adenocarcinoma in situ (AIS) showed either weak (predominantly) or moderate (occasionally) expression in about 40% of the cases in comparison with strong positivity in benign endocervical glandular epithelium.
  • Reduction of MGB staining was seen in transition from benign epithelium to AIS.
  • Most endocervical adenocarcinomas are negative for MGB, in contrast to mostly positive endometrioid endometrial adenocarcinomas, however, MGB expression alone is not specific enough to distinguish these 2 tumor types.
  • [MeSH-major] Adenocarcinoma / metabolism. Biomarkers, Tumor / biosynthesis. Carcinoma in Situ / metabolism. Neoplasm Proteins / biosynthesis. Uterine Neoplasms / metabolism. Uteroglobin / biosynthesis. Uterus / metabolism
  • [MeSH-minor] Cervix Uteri / metabolism. Endometrial Neoplasms / metabolism. Endometrium / metabolism. Female. Humans. Immunohistochemistry. Mammaglobin A. Uterine Cervical Neoplasms / metabolism

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18580321.001).
  • [ISSN] 1538-7151
  • [Journal-full-title] International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists
  • [ISO-abbreviation] Int. J. Gynecol. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Mammaglobin A; 0 / Neoplasm Proteins; 0 / SCGB2A2 protein, human; 9060-09-7 / Uteroglobin
  •  go-up   go-down


92. Tamai K, Togashi K, Ito T, Morisawa N, Fujiwara T, Koyama T: MR imaging findings of adenomyosis: correlation with histopathologic features and diagnostic pitfalls. Radiographics; 2005 Jan-Feb;25(1):21-40
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Adenomyosis is a nonneoplastic condition, characterized by benign invasion of ectopic endometrium into the myometrium with hyperplasia of adjacent smooth muscle.
  • The common symptoms include dysmenorrhea, menorrhagia, and abnormal uterine bleeding, but these do not allow diagnosis.
  • Therefore, imaging plays an important role because establishment of the correct preoperative diagnosis is critical to avoid unnecessary intervention.
  • Magnetic resonance (MR) imaging is a highly accurate noninvasive modality for diagnosis of adenomyosis, differentiation of adenomyosis from other gynecologic disorders, and planning of appropriate treatment.
  • Although the typical MR imaging findings are well established, adenomyosis actually varies widely in terms of histopathologic features (adenomyosis with sparse glands), growth patterns (polypoid adenomyoma, adenomyotic cyst, and miniature uterus), responses to hormonal activity (tamoxifen, decidual changes), and responses to treatment (gonadotropin-releasing hormone agonist).
  • The MR imaging findings of adenomyosis occasionally mimic those of uterine malignancy or ovarian cancer.
  • Furthermore, malignancy occasionally develops in otherwise benign adenomyosis.
  • Pitfalls in diagnosis of adenomyosis include myometrial contractions, leiomyoma, adenomatoid tumor, metastases, endometrial carcinoma, and endometrial stromal sarcoma.
  • Knowledge of the various appearances of adenomyosis and the possible pitfalls in differential diagnosis help guide the determination of appropriate treatment options.
  • [MeSH-major] Endometriosis / diagnosis. Magnetic Resonance Imaging
  • [MeSH-minor] Adult. Aged. Diagnosis, Differential. Female. Humans. Middle Aged

  • Genetic Alliance. consumer health - Adenomyosis.
  • MedlinePlus Health Information. consumer health - Endometriosis.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) RSNA, 2005.
  • (PMID = 15653584.001).
  • [ISSN] 1527-1323
  • [Journal-full-title] Radiographics : a review publication of the Radiological Society of North America, Inc
  • [ISO-abbreviation] Radiographics
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 32
  •  go-up   go-down


93. Revonta M, Raitanen J, Sihvo S, Koponen P, Klemetti R, Männistö S, Luoto R: Health and life style among infertile men and women. Sex Reprod Healthc; 2010 Aug;1(3):91-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Infertile women also had Chlamydia trachomatis infection, benign tumor in their uterus and intestinal disease more often than fertile women.
  • [MeSH-minor] Adult. Age Factors. Chlamydia Infections / microbiology. Chlamydia trachomatis. Cross-Sectional Studies. Female. Fertility. Finland. Humans. Hypersensitivity. Infertility, Female. Intestinal Diseases. Male. Middle Aged. Odds Ratio. Prevalence. Uterine Neoplasms

  • MedlinePlus Health Information. consumer health - Alcohol.
  • MedlinePlus Health Information. consumer health - Dietary Fats.
  • MedlinePlus Health Information. consumer health - Infertility.
  • MedlinePlus Health Information. consumer health - Smoking.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 Elsevier B.V. All rights reserved.
  • (PMID = 21122604.001).
  • [ISSN] 1877-5764
  • [Journal-full-title] Sexual & reproductive healthcare : official journal of the Swedish Association of Midwives
  • [ISO-abbreviation] Sex Reprod Healthc
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Dietary Fats; 0 / Fatty Acids
  •  go-up   go-down


94. Agdi M, Tulandi T: Minimally invasive approach for myomectomy. Semin Reprod Med; 2010 May;28(3):228-34
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Uterine fibroids are the most common benign tumor of the uterus in women of reproductive age.
  • In those with abnormal uterine bleeding, one should exclude other causes of abnormal vaginal bleeding including endometrial cancer.
  • Diagnosis of uterine fibroid is established by pelvic ultrasonography with or without saline infusion hysterosonography.
  • Intramural and subserous myomas in women who opt for nonsurgical treatment could be treated with uterine artery embolization (UAE), high-intensity focused ultrasound (HIFU), or medical treatment such as selective gonadotropin-releasing hormone agonists, progesterone receptor modulators, or aromatase inhibitors.
  • [MeSH-major] Leiomyoma / surgery. Minimally Invasive Surgical Procedures. Uterine Neoplasms / surgery

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • MedlinePlus Health Information. consumer health - Uterine Fibroids.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Thieme Medical Publishers.
  • (PMID = 20414845.001).
  • [ISSN] 1526-4564
  • [Journal-full-title] Seminars in reproductive medicine
  • [ISO-abbreviation] Semin. Reprod. Med.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 58
  •  go-up   go-down


95. Strissel PL, Swiatek J, Oppelt P, Renner SP, Beckmann MW, Strick R: Transcriptional analysis of steroid hormone receptors in smooth muscle uterine leiomyoma tumors of postmenopausal patients. J Steroid Biochem Mol Biol; 2007 Oct;107(1-2):42-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Transcriptional analysis of steroid hormone receptors in smooth muscle uterine leiomyoma tumors of postmenopausal patients.
  • Smooth muscle tumors are histologically separated into benign leiomyomas and malignant leiomyosarcomas.
  • Uterine leiomyomas represent benign clonal tumors often arising within the smooth muscle tissue of the human uterus.
  • Uterine leiomyomas develop after the start of the menstrual cycle, become symptomatic during middle age, and in most postmenopausal patients tumor regression occurs.
  • Rarely, leiomyomas progress to leiomyosarcomas, where many sarcomas have markedly reduced or no steroid hormone receptors, thus, evolve to a hormone non-responsive state.
  • Quantitation of steroid hormone receptors from benign uterine tumors may be important for a more tailored therapy.
  • In addition, a role for steroid hormones, specifically ERbeta, is discussed in terms of benign tumor regression or tumor maintenance in postmenopausal leiomyomas.
  • [MeSH-major] Estrogen Receptor alpha / biosynthesis. Estrogen Receptor beta / biosynthesis. Leiomyoma / metabolism. Postmenopause / metabolism. Receptors, Progesterone / biosynthesis. Uterine Neoplasms / metabolism

  • Genetic Alliance. consumer health - Uterine Fibroid.
  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • MedlinePlus Health Information. consumer health - Uterine Fibroids.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17646097.001).
  • [ISSN] 0960-0760
  • [Journal-full-title] The Journal of steroid biochemistry and molecular biology
  • [ISO-abbreviation] J. Steroid Biochem. Mol. Biol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Estrogen Receptor alpha; 0 / Estrogen Receptor beta; 0 / RNA, Messenger; 0 / Receptors, Progesterone
  •  go-up   go-down


96. Loffroy R, Nezzal N, Mejean N, Sagot P, Krausé D: Lipoleiomyoma of the uterus: imaging features. Gynecol Obstet Invest; 2008;66(2):73-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Lipoleiomyoma of the uterus: imaging features.
  • BACKGROUND: Lipoleiomyoma is an extremely rare, benign, uterine tumor that requires no treatment when asymptomatic.
  • METHODS: A uterine lipoleiomyoma in a 68-year-old asymptomatic woman exhibited highly suggestive features by ultrasound, multislice spiral computed tomography (CT), and magnetic resonance imaging (MRI).
  • RESULTS: The ultrasound findings were non-specific.
  • CT scan showed an 8 x 7 cm well-defined fatty mass of the uterine body.
  • On T(2)-weighted MR images, fat content within the tumor was confirmed because of evident chemical shift artifact.To our knowledge, the findings provided by these three modalities used in combination have not been reported previously in the gynecologic literature.
  • CONCLUSION: The data yielded by CT and MRI on the fatty nature of the lesion are valuable in diagnosing this entity.The final pathological examination results confirmed the diagnosis of lipoleiomyoma.
  • [MeSH-major] Leiomyoma / diagnosis. Lipoma / diagnosis. Uterine Neoplasms / diagnosis

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • MedlinePlus Health Information. consumer health - Uterine Fibroids.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2008 S. Karger AG, Basel.
  • (PMID = 18431071.001).
  • [ISSN] 1423-002X
  • [Journal-full-title] Gynecologic and obstetric investigation
  • [ISO-abbreviation] Gynecol. Obstet. Invest.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Switzerland
  •  go-up   go-down


97. Junaid I, Paz R, Salihu HM, Sharma PP, Aliyu ZY: Pseudo-Meig's syndrome with multiple synchronous benign and malignant pelvic tumors. Arch Gynecol Obstet; 2006 Feb;273(5):315-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pseudo-Meig's syndrome with multiple synchronous benign and malignant pelvic tumors.
  • BACKGROUND: Meig's and Pseudo-Meig's syndromes have been reported in association with several malignancies but the concomitant existence of multiple synchronous benign and malignant tumors in association with Pseudo-Meigs' syndrome has not been reported in the published literature.
  • Histological examination confirmed a right ovarian carcinoid tumor embedded within a mature cystic teratoma while the left ovary, fallopian tube and the uterus contained a poorly differentiated adenocarcinoma of the endometrium.
  • CONCLUSION: This is the first case report of Pseudo-Meig's syndrome in association with ovarian carcinoid tumor and multiple synchronous benign and malignant pelvic tumors.
  • [MeSH-major] Meigs Syndrome / complications. Pelvic Neoplasms / complications
  • [MeSH-minor] Adenocarcinoma / complications. Adenocarcinoma / pathology. Adenocarcinoma / surgery. Asthma / complications. CA-125 Antigen / blood. Carcinoid Tumor / complications. Carcinoid Tumor / pathology. Carcinoid Tumor / surgery. Endometrial Neoplasms / complications. Endometrial Neoplasms / pathology. Endometrial Neoplasms / surgery. Fallopian Tube Neoplasms / complications. Fallopian Tube Neoplasms / pathology. Fallopian Tube Neoplasms / surgery. Female. Humans. Hydrothorax / complications. Middle Aged. Ovarian Neoplasms / complications. Ovarian Neoplasms / pathology. Ovarian Neoplasms / surgery. Teratoma / complications. Teratoma / pathology. Teratoma / surgery. Uterine Neoplasms / complications. Uterine Neoplasms / pathology. Uterine Neoplasms / surgery

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16136360.001).
  • [ISSN] 0932-0067
  • [Journal-full-title] Archives of gynecology and obstetrics
  • [ISO-abbreviation] Arch. Gynecol. Obstet.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / CA-125 Antigen
  •  go-up   go-down


98. Solomon LA, Schimp VL, Ali-Fehmi R, Diamond MP, Munkarah AR: Clinical update of smooth muscle tumors of the uterus. J Minim Invasive Gynecol; 2005 Sep-Oct;12(5):401-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Clinical update of smooth muscle tumors of the uterus.
  • Smooth muscle tumors of the uterus represent a spectrum of diseases that range from benign leiomyoma to malignant leiomyosarcoma.
  • The leiomyoma is the most common of these neoplasms.
  • Clinically, it is important to fully understand the differences in clinical presentation, biologic behavior, and management for patients with benign leiomyoma, smooth muscle tumors of uncertain malignant potential, and leiomyosarcoma.
  • The goal of this review is to present the most recent information about common smooth muscle tumors of the uterus including their etiology, histopathology, radiographic and clinical presentations, and available treatment options.
  • [MeSH-major] Smooth Muscle Tumor / surgery. Uterine Neoplasms / surgery

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16213425.001).
  • [ISSN] 1553-4650
  • [Journal-full-title] Journal of minimally invasive gynecology
  • [ISO-abbreviation] J Minim Invasive Gynecol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 52
  •  go-up   go-down


99. Waalkes MP, Liu J, Ward JM, Powell DA, Diwan BA: Urogenital carcinogenesis in female CD1 mice induced by in utero arsenic exposure is exacerbated by postnatal diethylstilbestrol treatment. Cancer Res; 2006 Feb 1;66(3):1337-45
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Arsenic alone induced some urogenital system tumors, including mostly benign tumors of the ovary and uterus, and adrenal adenoma.
  • Diethylstilbestrol alone induced some tumors (primarily cervical) but when given after in utero arsenic, it greatly enhanced urogenital tumor incidence, multiplicity, and progression.
  • For instance, compared with the incidence of urogenital malignancies in the control (0%), arsenic alone (9%), and diethylstilbestrol alone (21%) groups, arsenic plus diethylstilbestrol acted synergistically, inducing a 48% incidence of malignant urogenital tumors.
  • Of the urogenital tumors induced by arsenic plus diethylstilbestrol, 80% were malignant, and 55% were multiple site.
  • Arsenic plus diethylstilbestrol increased ovarian, uterine, and vaginal tumors, and urinary bladder proliferative lesions, including three transitional cell carcinomas.
  • Tamoxifen alone did not increase urogenital tumors or affect arsenic-induced neoplasia but did increase arsenic-induced uroepithelial proliferative lesions.
  • Uterine and bladder carcinoma induced by arsenic plus diethylstilbestrol greatly overexpressed estrogen receptor-alpha (ER-alpha) and pS2, an estrogen-regulated gene.
  • [MeSH-major] Arsenic / toxicity. Diethylstilbestrol / toxicity. Genital Neoplasms, Female / chemically induced. Kidney Neoplasms / chemically induced. Prenatal Exposure Delayed Effects. Urinary Bladder Neoplasms / chemically induced
  • [MeSH-minor] Animals. Body Weight / drug effects. Drinking / drug effects. Drug Synergism. Estrogen Receptor alpha / biosynthesis. Estrogen Receptor alpha / genetics. Female. Gene Expression / drug effects. Maternal-Fetal Exchange. Mice. Pregnancy. Tamoxifen / toxicity. Uterus / drug effects. Uterus / metabolism. Uterus / physiology

  • MedlinePlus Health Information. consumer health - Arsenic.
  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. TAMOXIFEN .
  • Hazardous Substances Data Bank. DIETHYLSTILBESTROL .
  • Hazardous Substances Data Bank. ARSENIC, ELEMENTAL .
  • Mouse Genome Informatics (MGI). Mouse Genome Informatics (MGI) .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16452187.001).
  • [ISSN] 0008-5472
  • [Journal-full-title] Cancer research
  • [ISO-abbreviation] Cancer Res.
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CO / N01 CO 12400; United States / Intramural NIH HHS / /
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Estrogen Receptor alpha; 094ZI81Y45 / Tamoxifen; 731DCA35BT / Diethylstilbestrol; N712M78A8G / Arsenic
  •  go-up   go-down






Advertisement